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The Patient Protection and Affordable Care Act (PPACA) expanded access to insurance 
coverage and health care services for many citizens, and has increased access for women in 
particular by including preventive reproductive health services as essential health benefits. The 
current national rates of sexually transmitted infections (STIs), reproductive cancer diagnoses, 
and unintended pregnancy serve as major areas of concern for women’s health and public health.  
The present study examined how knowledge of the PPACA influences receipt of preventive 
reproductive health services among women. Results indicate that higher levels of knowledge of 
the PPACA are associated with a greater likelihood of receiving cancer and STI screenings, as 
well as contraceptive counseling, and that increasing contraceptive knowledge, rates of 
contraceptive counseling, and pap screenings are related to greater use of highly effective 
contraception. The present study offers support for increased outreach and education efforts, 
along with additional policy and provider involvement. 
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Are you covered? Examining how knowledge of the Patient Protection and Affordable 
Care Act influences use of preventive reproductive health services 
 
Introduction and Background 
Sexually transmitted infections (STIs), reproductive cancers, and unintended pregnancies 
are negative sexual health outcomes that result in significant personal and public health concerns. 
Previous research has illustrated that many different components of health care should be 
considered when attempting to evaluate and decrease the prevalence of these problems. A few of 
these components are access to health insurance (Garfield, Licata, & Young, 2014), knowledge 
of insurance options and how to utilize coverage and benefits (Hall, Fendrick, Zochowski, & 
Dalton, 2014), frequency of healthcare visits (Pourat, Tao, & Walsh, 2008), knowledge of sexual 
health resources and services (Dodson, Gray, & Burke, 2012; Frost, Lindberg, & Finer, 2012; 
Kaestle & Waller, 2011), and education about reproductive health (McMorrow, Kenney, & Goin, 
2014). 
 Existing research has found that insurance coverage is associated with positive 
health outcomes (Baicker, Taubman, & Allen, 2013; Geisler, Chyu, Kusunoki, Upchurch, & 
Hook, 2006; Sommers, Long, & Baicker, 2014). The Patient Protection and Affordable Care Act 
(PPACA), also referred to as “Obamacare,” was enacted with the primary intention of increasing 
insurance coverage for citizens through Medicaid expansion, federal subsidies, and the creation 
of lower-cost private policies. Another major goal of this legislation was to ensure that 
individuals had access to a higher minimum standard of care by requiring that insurance policies 
cover certain essential health benefits – many of which focus on the promotion of access to 
preventive health services. Although the PPACA was designed to benefit all American citizens, 
the legislation houses many provisions that are aimed at increasing access to health care for 
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women, such as the inclusion of pap smears, breast exams, and maternity care as essential health 
benefits to be covered by all insurance plans. However, while the policy has the potential to 
greatly improve access to services among the general population, and consequently improve the 
country’s overall health, it is just the starting point for achieving a healthier nation.  
Research has shown that even when individuals have health insurance, they may still be 
seeking services for basic care outside of primary care settings (Stephens, Cohen, Philip, & 
Bernstein, 2014), or not receive all of the services that they need (Chabot et al., 2011; Kalmuss 
& Tatum, 2007; Porter & Ku, 200). One significant barrier to healthcare utilization is the lack of 
awareness among the general public of the PPACA’s policies and what changes have been made 
to the insurance system (Gross et al., 2012). It is possible that individual understanding of health 
insurance coverage, as well as knowledge of sexual and reproductive health and services, 
influences the rate at which services aimed at improving reproductive health are utilized.  
Sexual and Reproductive Health 
Sexual and reproductive health is defined as ‘a state of physical, emotional, mental, and 
social well-being relating to sexuality and the reproductive system, its functions, and processes.’ 
Each year, 20 million new cases of STIs are estimated to occur in the United States, with 
younger individuals (15-24 years old) comprising half of those infections (Centers for Disease 
Control [CDC], 2013). Perhaps more alarming is the fact that many individuals are unaware that 
they are carrying an infection, making the spread of such STIs much more likely (CDC, 2013). 
Certain infections, such as HIV (Human Immunodeficiency Virus) are known to be detrimental 
to health; however, even infections that are considered to be less serious have the ability to cause 
problems such as ectopic pregnancy and infertility in women (CDC, 2013; Ochsendorf, 2008). 
Furthermore, contraction of any STI has been associated with an increase in the likelihood of 
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contracting HIV (Ochsendorf, 2008). In addition to the personal and public health impact, STIs 
in the country are estimated to cost 16 billion in direct medical costs alone each year (CDC, 
2013). 
Of the 20 million new infections that occur each year, HPV (Human Papillomavirus) is 
estimated to account for 14.1 million (CDC, 2013). While the majority of HPV infections have 
fewer long-term adverse health effects and are likely to clear up on their own over time, about 10 
percent of infections have the potential to lead to serious health issues such as cervical cancer 
(CDC, 2013), as well as vulvar, vaginal, anal, and oropharyngeal cancers (National Cancer 
Institute, 2012). While cervical cancer diagnoses have decreased considerably since the 
implementation of routine pap smears for women (National Institute of Health, 1996), more than 
12,000 women in the U.S. were diagnosed with cervical cancer in 2012 (US Cancer Statistics 
Working Group, 2015).  
Reproductive cancers can also be screened for using preventive health services. Uterine 
cancer, which is currently the fourth most common cancer among women in the United States, 
was diagnosed more than 47,000 times in U.S. women in 2011 (CDC, 2014). Breast cancer 
currently carries a 1 in 8 lifetime risk ratio for women, and it is estimated that 292,130 new cases 
of breast cancer will be diagnosed among women in the United States in 2015 (American Cancer 
Society, 2015).  
Unintended pregnancy is another negative health outcome–one that occurs at a 
significantly higher rate in the U.S. than in many other developed countries (Mosher & Jones, 
2010; Peipert, Madden, Allsworth, & Secura, 2012). Fifty-one percent of pregnancies each year 
in the U.S. are unintended (Jones & Dreweke, 2011). Unintended pregnancy is associated with a 
range of negative health outcomes for pregnant women, including increased rates of physical and 
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sexual abuse, mental health issues (i.e., depression, anxiety) (East, Chien, & Barber, 2012; 
Miller, Sable, & Beckmeyer, 2009; Sayil, Güre, & Uçanok, 2007), self-induced abortion, and 
maternal mortality (Fawcus, 2007; Sensoy, Dogan, Sen, Aslan, & Baser, 2015). Furthermore, 
unintended pregnancy is related to many negative consequences for the child, such as delayed 
prenatal care, premature birth, low birth weight, and poor mental and physical outcomes 
(Crissey, 2005; Jones, Mosher, & Daniels, 2012; The Alan Guttmacher Institute, 2000; Trussel, 
2011). 
Unintended pregnancy disproportionately affects those of lower-income, lower education 
levels, and minority status, as well as those who are unmarried and of younger age (18-24) (Finer 
& Zolna, 2016; Jones & Dreweke, 2011; Jones, Mosher, & Daniels, 2012). Of the roughly 4 
million births that occur annually (Martin et al., 2013; Monte & Ellis, 2014; US Census Bureau, 
2012), Medicaid is estimated to pay for 44 to 48 percent each year (Kaiser Family Foundation, 
2010; Markus et al., 2013; Sonfield, Kost, Benson Gold, & Finer, 2011; Stranges, Wier, & 
Elixhauser, 2012), as well as a significant amount of Neonatal Intensive Care Unit (NICU) costs 
(Institute of Medicine, 2007). Similarly, when considering all expenses associated with the one 
million unintended pregnancies that result in births each year, approximately $11 billion dollars 
are provided annually by American taxpayers (Gold & Sonfield, 2011).  
Abortion is an outcome that is inherently associated with unintended pregnancy. While 
the abortion rate for the country has been consistently decreasing for over a decade, three out of 
every ten women will have experienced an abortion by the time they reach 45 years of age (The 
Alan Guttmacher Institute, 2012). An estimated 40% of unintended pregnancies result in 
abortion each year (Jones & Jerman, 2011). The most recent numbers report that there were 1.1 
million abortions in 2011, equating to a rate of 16.9 abortions per 1,000 women annually (Jones 
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& Jerman, 2011). Resembling the demographic distribution of unintended pregnancy, abortion is 
more common among those with lower education levels and those of minority status (The Alan 
Guttmacher Institute, 2012). Of women who have abortions, 69% are of lower socioeconomic 
status, 61% have at least one child, 58% are in their twenties, and 56% are single (Jones & 
Kavanaugh, 2011).  
Barriers to Health Care 
Understanding of, access to, and utilization of health care services plays a major role in 
the prevention of negative sexual and reproductive health outcomes. Much research has shown 
that the general population lacks an informed understanding of sexual and reproductive health in 
terms of how STIs are transferred and affect personal health (Baer, Allen, & Braun, 2000; 
Kaestle & Waller, 2011; Yacobi, Tenant, Ferrante, Pal, & Roetzheim, 1999), how contraceptives 
work (Eisenberg, Secura, Madden, Allsworth, Zhao, & Peipert, 2012; Frost et al., 2012; Sokkary 
et al., 2013), and what services are available to meet sexual and reproductive health needs (Hall 
et al., 2014). Multiple studies have found that a lack of knowledge about HPV and its role in the 
development of genital warts and cervical cancer is a significant barrier to vaccination (Brewer 
& Fasekas, 2007; Giambi et al., 2011; Rosenthal et al., 2011). Cohen (2013) found that receiving 
STI information from the participants’ university significantly increased the likelihood that 
individuals would obtain the HPV vaccine. Studies have also found that low levels of awareness 
and understanding of long-acting reversible contraceptive (LARC) methods of birth control serve 
as a barrier to greater utilization (Dodson, et al., 2012; Teal & Romer. 2013). 
It is also widely understood that individuals tend to underestimate their actual risk levels 
for health problems. A study completed by Burak et al. (1997) found that 80 percent of women 
incorrectly considered themselves to be at no risk for contraction of sexually transmitted 
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infections. A similar study found that many women did not believe themselves to be at risk for 
contracting HPV when they were, in fact, at risk (Ratanasiripong, 2012). Yet another study 
completed by Kaestle and Waller (2011) found that 70 percent of sexual minorities with a 
bacterial STI rated their STI contraction risk as being very low. 
There are many mechanisms that influence access to care, and affordability serves as one 
of the most significant barriers. It has been shown that women of lower socioeconomic status are 
significantly more likely to experience an unintended pregnancy and abortion than their 
wealthier counterparts (Guttmacher Institute, 2014). Moreover, research has shown that many 
women list cost as a significant barrier to contraceptive use (Kavanaugh, Frohwirth, Jerman, 
Popkin, & Ethier, 2013; Peipert et al., 2012; Rose, Cooper, Baker, & Lawton, 2011), and that 
poorer women are less likely to be able to afford contraceptives – especially those that are 
longer-acting and more reliable (Gostin, 2014; Guttmacher Institute, 2014; Peipert et al., 2012; 
Ricketts, Klingler, & Schwalberg, 2014). The birth control pill, patch, and ring each carry a 
typical use failure rate of 9 out of every 100 women becoming pregnant in the first year of use, 
compared to 18 out of every 100 for male condom use, 6 out of 100 for injectables (e.g., Depo 
Provera), and .05-.08 out of 100 for arm implants and intrauterine devices (IUDs) (World Health 
Organization, 2011). Despite the failure rates associated with typical use of the pill being much 
higher than other hormonal methods of birth control, it still remains the most frequently used 
birth control method in the United States (Mosher & Jones, 2010).  
Research on the contraceptive CHOICE project in St. Louis found that when cost was not 
a consideration, 70 – 75 percent of women chose to use LARC methods (i.e., implants and IUDs) 
(Mestad, Secura, Allsworth, Madden, Zhao, & Peipert, 2011; Peipert et al., 2012). A similar 
study evaluated the Colorado Family Planning Initiative, which was designed to reduce 
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unintended pregnancy and abortion rates among teenagers by providing free LARC methods 
(Rickets et al., 2014). The authors found that by the end of the program, 19 percent of women in 
the 14-20 age group chose to use a LARC method. When compared to 5 percent LARC use at 
the start of the study, this growth translates to a four-fold increase in utilization (Ricketts et al., 
2014). The same study also found that the significant increase in LARC method use was almost 
equally matched by a 13 percent decrease in contraceptive pill use among their sample (Ricketts 
et al., 2014).    
Affordability has also been listed as a barrier to obtaining vaccinations and preventive 
cancer screenings. In multiple studies evaluating HPV vaccination rates, participants frequently 
cite high cost as a deterrent for receiving the vaccine (Burke, Vail-Smith, White, Baker, & 
Mitchelle, 2010; Bynum, Wright, Brandt, Burgis, & Bacon, 2009; Conroy, Rosenthal, Zimet, Jin, 
Bernstein, Glynn, & Kahn, 2009). Similarly, an evaluation of the effects of the Balanced Budget 
Act of 1997 (which eliminated costs associated with Part B deductibles for mammograms 
received through Medicare), showed that mammogram screening among Medicare patients 
increased 20% in the two years following the waiver, and 25% by year four (Goodwin & 
Anderson, 2012).  
Lack of insurance coverage as a barrier. Another substantial barrier to obtaining health 
care services is access to health insurance. People are more likely to forego health care services–
including preventive services–if they lack coverage, thus leading to poorer health outcomes 
(Kaiser Commission on Medicaid and the Uninsured, 2006). One study showed that 52% of 
women who reported postponing preventive services in 2013 due to cost were uninsured, 
compared to 42% of men (Kasier Family Foundation, 2015). Another study using a nationally 
representative sample showed that only 33% of individuals who were uninsured reported 
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receiving preventive screenings, compared to 67% of individuals who had Medicaid coverage, 
and 74% of those with private insurance (Garfield et al., 2014).  
Similarly, women are more likely to experience gaps in their insurance coverage, due to 
factors such as job patterns, relationship status, and being covered as a dependent (Fitzgerald, 
Cohen, Hyams, Sullivan, & Johnson, 2014; Patchias & Waxman, 2007). Women are more likely 
than men to be employed part-time, which results in ineligibility for employer-based insurance 
coverage (Fitzgerald et al., 2014). Women are also more likely to be insured through a partner’s 
plan, granting them dependent coverage and leaving them at risk of experiencing gaps in 
coverage during situations of partner job loss and divorce (Patchias & Waxman, 2007).  
The implications of this information are problematic when taking into consideration STI 
screening and diagnosis. One study found that young adult men with any health insurance 
coverage throughout the year or continuous coverage had a significantly lower risk for 
chlamydial infection, while for women, risk was only reduced for those with continuous 12-
month coverage (Geisler, 2006). In relation to HPV, possession of insurance coverage is linked 
to increased rates of cervical cancer screening (Kessels et al., 2012; Rodriguez et al., 2005). 
Receipt of the HPV vaccination is also associated with having insurance coverage, with the 
likelihood of receiving the vaccine increasing almost two fold among young women who are 
covered by their parents’ insurance (Cohen, 2013). Other studies have noted a lack of insurance 
coverage as one of the more common reasons cited for not having obtained the vaccine (Conroy 
et al., 2009; Holguin, 2010; Rosenthal et al., 2011: Zimet et al., 2010). 
Another study by Culwell & Feinglass (2007) found that among women aged 18-44 years 
old who were at risk for unintended pregnancy, those without insurance were 20-40% less likely 
to utilize prescription contraception. This finding held steady across all racial, financial, and 
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marital status groups. Of those using prescription methods, the most common was oral 
contraception (43%), followed by over-the-counter methods, such as condoms (21%), long-term 
prescription methods (10%), and “other” methods, such as withdrawal (10%) (Culwell & 
Feinglass, 2007). A rather substantial number of sexually active participants (17%) reported 
using no method of birth control at all (Culwell & Feinglass, 2007).  
The Patient Protection and Affordable Care Act 
In 2010, the year that the PPACA was signed into law, 16% of Americans were 
uninsured, 22.3% of 18-24 year olds were without insurance, and 7.8% of those under 18 years 
old were uninsured (Ward, Clarke, Freeman, & Schiller, 2015). At that time, research illustrated 
that preventive services were utilized at a rate that was well below the recommended rates 
(Lurie, Manning, Peterson, Goldberg, Phelps, & Lillard, 1987; Maciosek, Coffield, Edwards, 
Flottemesch, Goodman, & Solberg, 2006; Nelson, Bland, Powell-Griner, 2002; Smith, 
Cokkinides, Eyre, 2005). In addition to the rate of uninsured citizens and lack of preventive care 
utilization in the country, the costs of health care in the United States were (and still are) 
problematic. The United States spends more money on health care than any other country in the 
world while citizens experience subpar health care. Americans’ life expectancy is currently 
below that of leading countries who pay nearly half as much in per capita health care costs 
(Organisation for Economic Co-operation and Development, 2014). Medical costs for American 
citizens are also substantial, and contribute to approximately 60% of bankruptcies in the U.S. 
(Brill, 2013).  
Working to correct these issues served as a partial motivator for the development of the 
PPACA. Massachusetts’ 2006 Health Care Reform served as the basis for the development of the 
national health care legislation, with key elements such as the individual mandate, financial 
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subsidies, and minimum standards of care incorporated into the PPACA (The Henry J. Kaiser 
Family Foundation, 2012). While the health reform in Massachusetts has not yet been able to 
address all of the issues mentioned, significant increases in insurance coverage were attained and 
Massachusetts currently has a 96% insured rate, which is higher than that of any other state 
(Smith & Medalia, 2014). Racial minorities and those who were below 300% of the federal 
poverty level experienced higher gains in coverage than other groups, thus addressing a portion 
of the disproportionate gaps in coverage that previously existed (Van Der Wees, Zaslavsky, & 
Ayanian, 2013). The state also experienced a significant growth in preventive care use among 
adults, with service utilization increasing from just under 70% in 2006 to almost 76% in 2010 
(The Henry J. Kaiser Family Foundation, 2012). Higher rates of cervical cancer screening were 
reported in Massachusetts than in other New England states (Van Der Wees et al., 2013). 
Another study found increases in the receipt of breast and cervical cancer screening at 3 years 
after implementation of the reform, with the most significant growth in utilization occurring 
among low-income women (Sabik & Bradley, 2016).  
Expansion of Coverage and Benefits through the PPACA 
The passage of the PPACA (Patient Protection and Affordable Care Act) has expanded 
health insurance coverage to millions of previously uninsured Americans through a few 
significant changes. One of these changes was the requirement that insurance companies allow 
their policyholders to maintain coverage for their children up to the age of 26. This adjustment 
has the potential to greatly benefit women, as 25% of women aged 19-25 were uninsured in 2011 
(Kaiser Family Foundation, 2013). Because young adults have served as one of the largest 
uninsured groups, and make up a significant number of STI diagnoses and unintended 
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pregnancies, this expanded coverage also has the potential to be beneficial in the aim to reduce 
negative sexual health outcomes.  
Medicaid was also expanded (in states that opted to participate) to cover individuals up to 
138% of the poverty level, as well as able-bodied, single adults. Currently, 31 states have 
expanded Medicaid for their citizens (Including Washington, D.C.), 19 states have refused 
expansion, and Utah is considering expansion (Kaiser Family Foundation, 2015). Similarly, the 
PPACA has allowed for individuals between 138 and 400% of the poverty level to apply for 
federal subsidies, wherein the government pays a portion of an individual’s premiums in order to 
help them gain and maintain insurance coverage long-term. Previous studies have indicated that 
those below 400% of the federal poverty level will gain insurance at a higher rate than those 
above this bracket through the PPACA, as they possess a stronger need for federal aid in order to 
obtain insurance (Buettgens, Garrett, & Holahan, 2010; McMorrow, Kenney, & Goin, 2014). 
This is encouraging when considering that 53% of women who were uninsured in 2013 were 
below 138% of the federal poverty level, and 37% were between 139 and 399% of the federal 
poverty level (Kaiser Family Foundation, 2013). The PPACA has the potential to increase access 
to insurance coverage for many women who qualify for government assistance in the form of 
Medicaid or subsidies.  
Thus far, both of these policy changes have resulted in a significant number of women 
gaining insurance coverage. Medicaid has experienced a 19.3% increase in enrollment from 57.8 
million individuals enrolled in September 2013 to 70.0 million enrolled at the start of 2015, with 
states that have undergone Medicaid expansion experiencing higher rates of enrollment than 
states who have yet to expand (26% vs 8%, respectively) (Office of the Assistant Secretary for 
Planning and Evaluation [ASPE], 2015).  Additionally, 11.7 million people have enrolled in 
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coverage through the marketplace, and it is estimated that 57% of individuals who gained this 
coverage during the first period of open enrollment had previously been uninsured (ASPE, 2015; 
Hamel, Norton, Levitt, Claxton, Cox, Pollitz, et al., 2014) 
The expansion of coverage for sexual and reproductive health services was yet another 
significant change. The PPACA requires that the majority of insurance policies now provide 
coverage for preventive tests and screenings (e.g., pap smears, breast exams, STI testing), as well 
as hormonal contraception without requiring that the individual pay copay, deductible, or 
coinsurance charges. This expansion of preventive services removes cost barriers for many 
women, and has the potential to increase rates of STI testing, cancer screenings, and birth control 
use. It is estimated that over 137 million men, women, and children now have this preventive 
service coverage with no cost sharing requirements, with 55.6 million women gaining this access 
(ASPE, 2015). This aspect of the PPACA is particularly beneficial to women, because it removes 
the requirement of a referral from a primary care physician to see a OB/GYN, thus including 
women’s gynecological visits under the umbrella of basic health care (Kaiser Family 
Foundation, 2013). Considering that for many women, gynecologists serve as a primary care 
doctor, the inclusion of this care as a covered preventive health service has the potential to 
greatly increase access to care for women.   
Additionally, the inclusion of maternal and neonatal care under covered essential health 
benefits in all insurance plans has the ability to substantially improve maternal and fetal health, 
as well. Prior to the passage of the PPACA, only 13 percent of health plans in the individual 
market covered these services (National Women’s Law Center, 2009), while all insurance plans 
in Oregon, Massachusetts, and New Jersey provided maternity coverage, 22 states did not offer a 
single plan with these benefits (Collins, Rustgi, & Doty, 2010). While the option to add on 
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maternal care coverage was available for some plans, women were required to purchase a 
separate rider that was often very costly and carried a waiting period (Kaiser Family Foundation, 
2013). Moreover, the PPACA removes the classification of pregnancy as a pre-existing 
condition, thus enabling pregnant women to gain coverage without rejection from insurance 
carriers (Kaiser Family Foundation, 2015). As pregnancy-related issues and childbirth are listed 
as the leading source of hospitalization in the country, the addition of this care as an essential 
health benefit has the potential to address some of the negative health outcomes associated with 
unintended pregnancy and receipt of care (Kaiser Family Foundation, 2015). 
Beyond the Legislation 
Although a recent report from the U.S. Census Bureau (2015) indicates that a large 
majority of individuals (approximately 284.3 million) now have health insurance, while a much 
smaller minority (approximately 33 million) are uninsured, access to insurance coverage and 
health care providers does not serve as a guarantee that individuals will utilize preventive health 
care services. One study found that although one-third of patients at an STI clinic reported 
having insurance at the time of their care, they still chose to forego use of their health insurance 
and seek care at the clinic rather than with a primary care doctor (Stephens et al., 2014). 
Nevertheless, research has shown that higher rates of health care visit are related to positive 
health outcomes (Baicker, Taubman, & Allen, 2013; Sommers, Long, & Baicker, 2014). Pourat 
and colleagues (2008) found that young women who had participated in five or more doctor 
visits in the previous year (compared to those who did not participate in any visits) were more 
likely to be screened for Chlamydia. Furthermore, receiving a pap smear or clinical breast exam 
was associated with a greater likelihood that women would be screened for Chlamydia as well 
(Pourat et al., 2008). 
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Knowledge as a Barrier 
Following the passage of the PPACA, many individuals are still largely unaware of how 
to sign up for plans or how to dissect the language of insurance (Sobel, Salganicoff, & Kurani, 
2015). Many individuals are signing up for low-premium, high-deductible plans that could 
potentially lead them into bankruptcy should a major health issue arise. A study by Sonier, 
Boudreaux, and Blewett (2013) showed that stronger state outreach efforts equate to higher rates 
of individuals acquiring health insurance. Presumably, stronger outreach efforts would also lead 
to individuals being more knowledgeable about their coverage, how to use it, and what 
restrictions they may have.  
Similarly, many citizens are still unaware of the PPACA’s policies and how it affects 
their coverage and access to services. One study assessing knowledge about the PPACA found 
that understanding of the elements of the legislation was limited when participant certainty about 
their responses were factored into scoring (Gross et al., 2012). In this study, 84.2 percent of 
individuals got 9 or more items (out of 18) correct with varying levels of certainty recorded 
compared to only 18.9 percent of individuals getting 9 or more items correct with high levels of 
certainty (Gross et al., 2012). Furthermore, this study found that understanding of the legislation 
had not notably changed between the year that the law was passed and 2012, with 14.9 percent of 
individuals scoring correctly on 9 items with high certainty in 2010 compared to 18.9 percent in 
2012 (Gross et al., 2012). Another study of women showed that while 80 percent of women 
surveyed had heard of the PPACA, only 24 percent of women expected their insurance coverage 
to change as a result of its policies (Hall et al., 2014). The same study showed that those who 
were less-educated, poorer, and uninsured were less likely to understand the changes that the 
PPACA meant for their coverage (Hall et al., 2014). With the PPACA improving access to 
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various preventive health services for women across the country, a lack of knowledge about the 
policy has the potential to result in less positive change than is possible under the new 
legislation. If women are unaware of the new services and options that are available to them at 
no or reduced cost through their insurance coverage, then it is less likely that they will utilize the 
preventive services that the PPACA provides access to. 
Theoretical Framework: The Health Belief Model (HBM) 
 The health belief model was used as the theoretical framework for this study because of 
the substantial support it has received in the literature as a strong framework for understanding 
how individuals make decisions about their health (Janz & Becker, 1984). The health belief 
model was one of the first theories developed to explain health behaviors (National Cancer 
Institute [NCI], 2005). This model was developed by social psychologists working for the U.S. 
Public Health Service, with the aim of explaining why people were utilizing disease prevention 
and detection programs at much lower rates than expected (Hochbaum, 1958; Rosenstock, 1960, 
1966, 1974). There are 6 constructs that comprise the Health Belief Model, which are outlined 
below and in figure 1 (Champion & Skinner, 2016; NCI, 2005): 
1. Susceptibility refers to perceptions of risk related to contracting a certain condition, 
2. Severity refers to beliefs about how serious an issue or condition is, or how strongly it 
may affect one’s health or wellness, 
3. Benefits refer to beliefs about how positive engaging in a certain health action may be, or 
how effective the health action may be in reducing susceptibility or severity of a condition, 
4. Barriers refer to beliefs about the negative aspects or outcomes, or costs (e.g., physical, 
psychological, etc.) of engaging in the health action, 
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5. Cues to action refer to any factor that may trigger engagement in a health action or a 
desire to engage in the health action, and 
6. Self-efficacy refers to beliefs about the individual’s capabilities to engage in the health 
activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The Health Belief Model (modified slightly from Glanz et al., 2002, p.52). 
The Health Belief Model and Preventive Reproductive Health Service Use 
This model has been applied to various populations and a plethora of health behaviors, 
and has been used to address public health concerns (Conner & Norman, 1996; Chamption & 
Skinner, 2016). This includes preventive health behaviors, such as cancer screening, vaccination 
uptake, and birth control use behaviors, as well as clinical use behaviors, such as physician visits 
(University of Twente, 2016; Yarbrough & Braden, 2001). The dimensions of the health belief 
model are substantially supported by empirical evidence as significant predictors of individuals’ 
engagement in various health behaviors (Janz & Becker, 1984). 
However, in practice, the Health Belief Model is often broken down and used to assess 
one or more of the above components on their own (Crepaz & Marks, 2002; Yarbrough & 
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Braden, 2001). Reviews of the existing literature show that the tools and approaches used to 
assess the dimensions of this model are amenable while maintaining significant explanatory and 
predictive ability (Janz & Becker, 1984). Thus, the broad definitions for each dimension and the 
ability of the model to withstand adaptations allows for the investigation of factors that were not 
intended for use with this psychosocial model, but fit conceptually. The present study focuses on 
the modifying factors of group differences (i.e., age, race/ ethnicity, socioeconomic status, and 
education) and cues to action (i.e., the passage of the PPACA and promotion of preventive 
reproductive health services as essential health benefits to be covered without cost-sharing) 
outlined above in relation to perceived benefits and barriers in determining the likelihood of 
female use of preventive reproductive health services.  
Present Research 
The purpose of the present research was to examine the relationships among knowledge 
of coverage, consistency of coverage, and receipt of reproductive health services. Although 
previous research has examined relationships between insurance coverage and the receipt of 
health care, the changes resulting from the recent passage of the PPACA, as well as patient 
understanding of insurance requirements and benefits have not been adequately evaluated. 
 Hypothesis 1a-1b: In line with preceding research (Kessels et al., 2012; 
Rodriguez et al., 2005), it was hypothesized that consistency of insurance coverage would be 
related to an increased frequency of preventive health care visits, such as STI testing, 
reproductive cancer screenings, and birth control visits and services. As an extension of previous 
findings (Ricketts et al. 2014) it was hypothesized that those with consistent insurance coverage 
would have obtained long-acting reversible contraceptives (LARC) at a higher rate than those 
with inconsistent or no insurance coverage. 
 18 
 
 Hypothesis 2: Consistent with past research (Hall et al., 2014) it was 
hypothesized that those with less education and lower socioeconomic status will have less 
knowledge of the PPACA and insurance benefits, and will utilize fewer preventive reproductive 
health services. Furthermore, it was hypothesized that those with consistent health insurance 
coverage (Geisler et al., 2006), as well as those with more knowledge of the PPACA and its 
provisions would be more likely to utilize preventive reproductive health services.  
 Hypothesis 3: In line with the findings of Gostin (2014) and Finer and colleagues 
(2012), it was hypothesized that women who are of younger age and possess less education 
would be less likely to adopt LARC methods of contraception. Moreover, it was hypothesized 
that those possessing consistent health insurance coverage would be more likely to adopt LARC 
methods (Culwell & Feinglass, 2007; Mestad et al., 2011; Ricketts et al., 2014). Finally, it was 
hypothesized that individuals who have more knowledge about the policies of the PPACA would 
have an increased likelihood of using LARC methods. 
Method 
Sample & Procedure 
 Post hoc power analyses were run separately for the outcomes of preventive service use 
and LARC use using G*Power software (Faul, Erdfelder, Buchner, & Land, 2009). When 
conducting the analysis for the outcome of preventive service use with the participants in the 
sample who identified as female (n=693), it was determined that this sample size was sufficient 
to detect a moderate effect at .90 (90%). When conducting the analysis for the outcome of LARC 
use with those not at risk for pregnancy removed from the sample (n=488), it was determined 
that this sample size was sufficient to detect a moderate effect at .90 (.90%).  
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 A survey was administered to women across the United States who were between the 
ages of 18 and 44 using Amazon Mechanical Turk (MTurk). MTurk is a crowdsourcing website 
where individuals who are referred to as “workers” complete web-based tasks (usually, but not 
always) in exchange for monetary compensation. In MTurk, workers complete “Human 
Intelligence Tasks” (HITs) set up by “requesters” (who are the employers) that can range from 
providing feedback on media advertisements to passage translation to handwriting transcription 
to product rating, and more (Azzam & Jacobson, 2013; Berinsky, Huber, & Lenz, 2012). More 
recently, MTurk has also gained the interest of researchers as a platform for conducting research 
with human subjects. 
Multiple studies evaluating MTurk have found that the research participants (“workers”) 
are generally representative of the general United States population (Berinsky, Huber, & Lenz, 
2012; Crump, McDonnell, & Gureckis, 2013; Shapiro, Chandler, & Mueller, 2013). MTurk 
samples have been shown to align closely with the regional distribution of the country (Simons 
& Chabris, 2012), as well as racial and gender distributions (Azzam & Jacobson, 2013; Berinsky 
et al, 2012). In these ways, MTurk has been shown to be more diverse than other internet 
samples or college student samples (Berinsky et al., 2012; Buhrmester, Kwang, & Gosling, 2011, 
Ross, Ivani, Silberman, Zaldivar, & Tomlinson, 2010). However, some demographic differences 
have been found among the MTurk sample. MTurk workers have been found to possess higher 
income levels than phone survey samples (Simons & Chabris, 2012), but lower income levels 
than those comprising face-to-face interview samples (Berinsky et al., 2012), as well as higher 
levels of education than the general population (Ross et al., 2010). Researchers agree that despite 
the differences that MTurk may display from other survey methods, the crowdsourcing site is a 
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valid resource for recruitment and data collection, and that MTurk workers are largely 
representative of the United States population. 
MTurk requires that individuals be at least 18 years of age in order to register a worker 
account. Those above the age of 44 were excluded, as reduced reproductive health risk levels and 
less need for certain services among this age group leads to reduced rates of utilization of many 
of the reproductive health care services that were evaluated (Frost, 2013). The current study 
aimed to survey a varying age range of adult women who were likely to be affected by the 
PPACA and utilize preventive reproductive health services. Furthermore, a filter was applied 
within Mturk that restricted eligibility to people living in the U.S. only, and residency was 
verified through participant’s responses to the survey item asking them to report which state they 
lived in. Individuals residing outside of the U.S. are not subject to the PPACA legislation, and 
thus were not a focus of interest for this study. 
Data were collected from February until April 2016. A total of 708 participants 
completed the survey. The description of the study indicated that the survey items pertained to 
preventive health care services and health care policy. When participants opened the HIT in 
MTurk, they were provided with a link that took them to the Survey Monkey website to 
complete the survey. Once participants were in this webpage, they reviewed an electronic 
notification statement, which indicated that participation in the study was voluntary (See 
Appendix A). Participants were required to indicate that they were at least 18 years of age and 
wanted to participate in the study before they were able to access the survey. Participants were 
informed via the consent document that certain demographic characteristics were required to 
participate in the study, and were required to respond to a brief set of demographic questions 
before proceeding. Participants were not informed of the desired demographic characteristics 
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(i.e., age range and sex) before completion of the demographic questions, and were either taken 
to a page that informed them that they did not qualify for the study or were allowed to continue 
through the rest of the questionnaire.  
Participants were also informed via the consent document that in order to receive 
compensation for their participation, they must correctly respond to two out of three quality 
assurance questions, and would be paid $0.45 upon successful completion of the study. 
Participants were also required to enter a six-digit code in both Survey Monkey and MTurk in 
order to receive compensation. Once the codes were matched across online platforms, 
compensation was authorized. IP addresses were collected initially as a quality control measure 
to ensure that participants had not submitted duplicate entries, but were removed from the saved 
dataset once data quality had been evaluated. The present study was approved by the Institution 
Review Board (IRB at Virginia Commonwealth University (VCU).  
Materials 
 Demographics. Participants provided information about their age, gender, race/ 
ethnicity, sexual orientation, relationship status, educational attainment, income level, household 
size, and state of residence (See Appendix B for full questionnaire). Gender was asked to ensure 
that participants who identified as male were excluded from this study, and age was asked 
primarily to ensure that participants were between the ages of 18 and 44. Income level, 
household size, and state of residence were asked in order to determine each participant’s 
financial standing as a percentage of the federal poverty level. Percentage of the federal poverty 
level was calculated using the 2015 poverty guidelines provided by the US Department of Health 
and Human Services, where household size for each participant was multiplied by the poverty 
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guideline for their state of residence. If participants did not provide their state of residence, the 
poverty guidelines for the 48 contiguous states and the District of Columbia were used.  
 Health Insurance Information. In order to gain an understanding of participants’ 
insurance status, questions were posed about the consistency of their health insurance coverage 
during the previous year, the type of insurance plan that they have, and whether their health 
insurance plan is considered to be a grandfathered plan. The item assessing consistency of health 
insurance coverage during the previous year was a modified version of the item used by Geisler 
and colleagues (2006), and includes the following response options: (1) “I was not insured at all 
in the past year,” (2) “I was insured for 1-6 months out of the last year, (3) “I was insured for 7-
11 months out of the last year,” and (4) “I was insured for all 12 months of the last year.”  
Health insurance plan type was assessed at a broad level of public versus private 
insurance, consistent with other studies (Culwell & Feinglass, 2007; Smith & Medalia, 2014), 
but was also broken down further into plan types, with the goal of gaining a more accurate and 
detailed view of health insurance coverage types. Private insurance plan types were as follows: 
(a) a plan through an employer, (b) federal government insurance (for federal employees), (c) a 
plan through the government exchange/ Marketplace, (d) coverage through a parent’s plan, or (e) 
coverage through a university plan. Public insurance plan types were: (a) military insurance 
(Tricare), (b) Medicaid/ state program insurance, (c) Medicare, (d) veteran benefits. 
Preventive Reproductive Health Service Utilization. Participants were asked to 
provide information about their preventive reproductive health care-seeking behavior during the 
previous year. Participants provided information about which types of health care facilities they 
used in the previous year (i.e., doctor’s offices, free clinics, emergency rooms). Participants were 
also asked to indicate what, if any, preventive reproductive health services they utilized over the 
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previous year (e.g., reproductive cancer screenings, STI testing, and birth control counseling and 
visits). Because of the medical guidelines surrounding pap smears, receipt of this service was 
evaluated through the question “when was the last time that you received a pap smear” so that 
responses could be applied to the suggested three-year time-frame.  
Participants were also asked to report what, if any, birth control methods they had used 
during the previous year. Birth control use was classified based on efficacy of the method using 
the following five categories: (1) None/ no birth control, (2) Non-hormonal, (3) Hormonal, (4) 
LARC, and (5) Sterilization. For individuals who reported using more than one birth control 
method during this time, and used methods that fell into separate categories, categorization was 
based on the most efficacious form of birth control reported (e.g., those who used a non-
hormonal method and a hormonal method of birth control were categorized as having used a 
hormonal method during the previous year). Additionally, participants were asked to report 
whether they received pregnancy, miscarriage, or abortion care during the previous year, as well 
as whether they were attempting to become pregnant during this span of time.  
Sexual Behavior. Participants reported their total number of male and female sexual 
partners over the past three months, as well as their total number of unprotected vaginal or anal 
sex acts and any STI diagnoses they received during this time frame. Participants also reported 
their total number of male and female sexual partners, and indicated whether they had ever been 
diagnosed with an STI. 
Knowledge of the PPACA. In order to gauge participant knowledge of the PPACA, a 
modified version of the knowledge quiz created by Gross and colleagues (2012) was 
administered. This quiz contained 31 knowledge questions inquiring as to whether certain 
provisions are part of the health care law or not, with response options of “True” and “False.” 
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For each knowledge item, participants were asked to indicate their level of certainty that their 
response was correct on a 1 (not sure at all) to 5 (extremely sure). The 31 items are divided into 
three categories: (1) plan requirements and provisions, (2) benefits and services, and (3) 
government and taxing. Participant responses were scored on a scale of 0-31, indicating the 
number of correct responses provided. This method yielded a very low reliability for this sample 
(α = .574).  
The items were then scored with the number of items that participants got correct and 
indicated that they were either “very sure” or “extremely sure” about categorized as being 
correct, while incorrect responses and correct responses that were followed with “moderately 
sure,” “slightly sure” or “not sure at all” were considered incorrect. This method yielded a much 
higher level of reliability for this sample (α = .893). This second method of scoring was used in 
analyses to account for the effects of random guessing because previous research reported a large 
difference between those who answered items correctly and those who answered items correctly 
with a high level of certainty (Gross et al., 2012).  
When items were scored with the number of items that participants got correct and 
indicated that they were “moderately sure,” “very sure,” or “extremely sure” about categorized 
as being correct, and incorrect responses and correct responses followed with “slightly sure” or 
“not sure at all” considered incorrect, results were consistent with the scoring method used for 
analyses in the present study.  
Birth Control Knowledge. A shortened version of a contraception knowledge survey 
was used to evaluate participants’ understanding of the various available birth control methods 
(Kaye, Suellentrop, & Sloup, 2009). This knowledge inventory had 14 items, and the response 
options were “True” and “False.” For this sample, the reliability of the measure was α = .781.  
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Quality Assurance. In order to reduce random response rates and promote greater data 
quality, three questions were placed in the survey as quality assurance items. Two of these items 
were true/ false items (items 122 and 219), and the third is a short answer item (item 264). 
Participants were notified in the informed consent document that if they failed to correctly 
answer two out of three of these items, then they would not receive compensation. Additionally, 
participant data was removed for those individuals who failed two out of three of the quality 
assurance items. 
Results 
Demographic Information 
 Sample demographic information is shown in Table 1. The average age of participants 
was 31 years. The sample was also majority white, and largely consisted of those who had 
received their Bachelor’s degree, and were married. When compared to the 2015 state population 
estimates published by the U.S. Census Bureau, the current sample was geographically 
representative at r = .942, p<.001.   
Table 1.  
Sample demographic characteristics  
Characteristic Means (SD)/ Percentages (n) 
Age (Years) Mean= 30.94 (SD=6.69) 
Gender  
Female 97.9% (693) 
Transgender Male 1.1% (8) 
Transgender Female 0.4% (3) 
Gender Non-Conforming 0.4% (3) 
Race/ Ethnicity  
Caucasian 76.7% (543) 
African American 8.8% (62) 
Hispanic/ Latino 5.4% (38) 
Asian 5.1% (36) 
Multiracial 1.3% (9) 
American Indian/ Alaskan Native 0.8% (6) 
Native Hawaiian or Other Pacific Islander 0.4% (3) 
“Other” 1.6% (11) 
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Education  
Middle school 0.3% (2) 
GED 2.4% (17) 
High School 19.2% (136) 
Vocational School 6.4% (45) 
Associates Degree 15.5% (110) 
Bachelor’s Degree 42.9% (304) 
Graduate Degree (Master’s, Doctorate) 13.1% (93) 
Relationship Status  
Not currently dating or in a relationship 18.6% (132) 
In a newer relationship with 1 person  
(less than 12 months) 
10.9% (77) 
In a long-term relationship with 1 person 
 (12 months or longer) 
27.1% (192) 
Married 40.4% (286) 
Dating/ in a relationship with more than 1 person 2.1% (15) 
Geographical Region  
Northeast 18.6% (132) 
Midwest 23.3% (165) 
South 35.0% (248) 
West 22.2% (157) 
N = 708 
SD = Standard deviation 
 
Preventive Reproductive Health Service Use and Demographic variables 
 A substantial majority of participants reported using a preventive reproductive health 
service during the previous year. Following the most recent medical guidelines, pap screenings 
were evaluated based on the last three years (71.6%, n = 507) (Table 2). The majority of 
participants had received a pap smear within the previous three years. Additionally, many 
participants reported receiving a well woman’s exam or physical, a pelvic exam, and/ or a breast 
exam during the previous year. Fewer participants had received birth control counseling or STI 
testing during the previous year. A small number of participants reported using LARC methods 
during the previous year.    
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Table 2. 
Rates of preventive reproductive health service utilization 
 Did not receive 
service % (n) 
Did receive 
service % (n) 
Pap smear, last 3 years 27.4 (190) 72.6 (503) 
Well woman’s exam/ physical, last year 35.8 (248) 64.2 (445) 
Pelvic exam, last year 45.6 (316) 54.4 (377) 
Breast exam, last year 53.1 (368) 46.9 (325) 
Birth control counseling, last year 69.1 (479) 30.9 (214) 
STI testing, last year 74.6 (517) 25.4 (176) 
LARC methods of birth control, last year 86.1 (597) 13.9 (96) 
N = 693   
 There was no significant difference in preventive reproductive health service utilization 
between White and non-White participants, x2 (1, n = 693) = 2.019, p=.155. There were also no 
significant differences in service use based on sexual orientation, x2 (6, n = 693) = 10.346, 
p=.111. However, there were significant differences in service utilization based on highest 
achieved education and relationship status (Table 3).  
Table 3. 
Differences in service use based on education and relationship status 
 Did not use 
preventive services, 
last year (n = 193) 
Used preventive 
services, last 
year (n = 494) X2 
Education % %  
Middle School 0a 0.40a 
21.943** 
GED 1a 3.0a 
High School 28.2a 15.1b 
Vocational School 7.5a 6.0a 
Associates Degree 16.4a 15.3a 
Bachelor’s Degree 37.4a 45.3a 
Graduate Degree (Master’s, Doctorate) 9.2a 14.9b 
Relationship Status % %  
Not dating or in a relationship 24.9a 15.6b 
12.300* 
Newer relationship (<12 months) with 
1 person 
9.8a 11.3a 
Long-Term relationship                 
(>12 months) with 1 person 
28.0a 27.1a 
Married 36.3a 43.3a 
In a relationship with > 1 person 0.5a 2.6a 
N = 693  
*p<.05, **p<.01, ***p<.001 
Columns with different superscripts differ significantly (Bonferroni corrected) 
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Preventive Reproductive Health Service Use and Duration of Insurance Coverage 
 The majority of participants reported having insurance coverage for all 12 months of the 
previous year (78.2%, n = 541), while 7.9% (n = 55) reported having insurance for 7-11 months 
out of the year, 5.2% (n = 36) reported having insurance for 1-6 months out of the year, and 
8.7% (n = 60) reported not being insured at all during the previous year. Additionally, 74.5% (n 
= 527) of those who had insurance reported having a private insurance plan, and 23.3% (n = 165) 
reported having a public insurance plan (See Table 4). Additionally, 60.0% (n = 425) of 
participants indicated that they were the policy holder, while 36.4% (n = 258) indicated that they 
were a dependent on the plan.  
Table 4. 
Insurance information 
 
Insurance plan type Percentage (n) 
None 7.1% (49) 
Private 70.3% (487) 
Through an employer 49.5% (343) 
Through the exchange/ marketplace 11.4% (79) 
Through a parent’s plan 10.0% (69) 
Through a university 2.3% (16) 
Not sure 2.6% (18) 
Public 22.7% (157) 
Military insurance 3.9% (27) 
Medicaid/care (state program)  22.4% (155) 
Not sure 1.9% (13) 
Both public and private insurance coverage 5.5% (38) 
N = 693 
Percentages are computed out of the entire sample 
 
Knowledge of the PPACA 
 
Participant responses were first scored on a scale of 0-31, indicating the number of 
correct responses provided. Using this scoring method, the average score was 19.7 (SD = 3.88) 
and scores ranged from 7 – 29. As previously stated, this method yielded a very low reliability 
and was not used in hypothesis testing. Information for the three subscales is presented in table 5. 
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The PPACA knowledge measure used was scored by summing the number of items that 
participants got correct and indicated that they were either “very sure” or “extremely sure” about 
categorized as being correct. Incorrect responses and correct responses that were followed with 
“moderately sure,” “slightly sure” or “not sure at all” were considered incorrect. This scoring 
method resulted in an average score of 5.97 (SD = 5.70), and a range of 0 – 29. This method 
yielded a much higher level of reliability for this sample (α = .893), and was used in analyses to 
account for the effects of random guessing (Gross et al., 2012). Information for the three 
subscales is presented in table 5. 
Table 5. 
Performance and scoring information for PPACA knowledge scale and subscales 
 Number of 
items in scale Mean (SD) 
Cronbach’s 
alpha (α) 
Number of correct responses provided 
Full Scale 31 19.72 (3.88) .574 
Requirements and provisions subscale 10 7.29 (1.73) .462 
Benefits and services subscale 13 8.32 (2.12) .325 
Government and taxing subscale 8 4.89 (1.38) .122 
Number of correct responses provided, with high certainty 
Full Scale 31 5.97 (5.70) .893 
Requirements and provisions subscale 10 2.45 (2.38) .781 
Benefits and services subscale 13 1.87 (2.46) .808 
Government and taxing subscale 8 1.70 (1.68) .663 
N = 693 
 
   
Hypothesis 1a 
 A Chi square analysis was conducted to determine whether the amount of time during the 
past year that an individual possessed health insurance coverage was related to differences in the 
receipt of STI testing, reproductive cancer screenings, and birth control visits and services. For 
this analysis, the amount of time that an individuals had health insurance coverage was based on 
four possible responses: (1) “I was not insured at all in the past year,” (2) “I was insured for 1-6 
months out of the last year,” (3) “I was insured for 7-11 months out of the last year,” and (4) “I 
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was insured for all 12 months out of the last year.” Preventive health service use was 
transformed into binary categories (where necessary) for each category of services.   
 There were significant differences in the receipt of various types of reproductive cancer 
screening based on duration of health insurance coverage over the previous year (Table 6). 
Receipt of a pap smear within the last 3 years, a pelvic exam in the last year, a breast exam in the 
last year, and a physical or well woman’s exam in the last year, all showed a similar pattern of 
difference in service use across insurance coverage duration. Those who did not possess 
insurance coverage at all during the previous year had significantly lower rates of utilization for 
each type of reproductive cancer screening. There were also significant differences in the receipt 
of STI testing and birth control counseling based on duration of health insurance coverage over 
the previous year. Again, those who had no insurance coverage during the previous year had 
significantly lower rates of service receipt for both STI screening and birth control counseling. 
Table 6. 
Differences in service use based on duration of insurance coverage during the previous year 
 Not insured 
at all in last 
year         
(n = 60) 
Insured for 
1-6 months 
of last year 
(n = 36) 
Insured for 
7-11 months 
of last year 
(n = 55) 
Insured for 
all 12 months 
of last year  
(n = 541) X2 
Cancer Screenings % % % %  
Pap smear, last 3 years 33.3a 66.7b 72.7b 77.3b 52.991*** 
Pelvic exam, last year 16.7a 45.4b 44.1b 60.3b 46.040*** 
Breast exam, last year 11.7a 33.3a,b 40.0b 52.3b 39.986*** 
Physical/ well woman’s 
exam, last year 
21.7a 58.3b 67.3b 68.9b 53.270*** 
      
Other Prev. Services % % % %  
STI testing, last year 11.6a 33.3b 20.0a,b 27.0b 8.725* 
Birth control 
counseling, last year 
8.3a 38.9b 29.1b 32.9b 16.517** 
N = 693 
*p<.05, **p<.01, ***p<.001 
Columns with different superscripts differ significantly (Bonferroni corrected) 
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Hypothesis 1b 
 Another chi square analysis was computed to determine whether consistent health 
insurance coverage is related to differences in the utilization of LARC methods. For this 
analysis, insurance coverage was based on the same four categories previously mentioned, and 
LARC method use was transformed into binary categories of use (0 = No, 1 = Yes). This 
analysis was restricted to women who are at risk for pregnancy, including those who identify as 
female, are sexually active and report engaging in sex with men, have not been sterilized, and 
those who were not attempting to become pregnant during the previous year. This excluded 228 
women, and resulted in a sample size of 480 women for this analysis. There were no significant 
differences in LARC use based on the duration of insurance coverage, x2 (3, n = 480) = 4.063, 
p=.255. A subsequent analysis comparing the use of any non-hormonal form of birth control to 
the use of any hormonal form of birth control (including LARC methods) also showed no 
significant differences across duration of insurance coverage, x2 (3, n = 480) = 5.752, p=.124.   
 Hypothesis 2 
A three stage hierarchical logistic regression was used to test the hypothesis that 
knowledge of the PPACA predicts utilization of preventive reproductive health services 
(excluding services for birth control prescriptions or devices). Use of preventive health services 
was entered into the model as a binary outcome based on having not received preventive health 
services (n = 195) or having received these services (n = 496) (Table 7). Demographic factors 
[i.e., age, race, education level, and income (as a percentage of the federal poverty level)] were 
entered in at stage one of the model, and significantly predicted preventive service use when 
compared to the constant-only model, x2 (4, N=693) = 17.238, p<.01. As education level 
increased, the likelihood of having used preventive reproductive health services increased as 
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well, with those who had obtained more education being 1.099 times as likely to have received 
services (p<.05; b = .094; 95% CI = 1.968, 1.248).  
The number of months participants indicated having health insurance coverage was entered 
in at stage two of the model, and significantly added to the predictive utility of the model, x2 (1, 
N=693) = 37.251, p<.001. Those who had insurance coverage for a longer span of time during the 
year were 1.7 times more likely to have utilized these services (p<.001; b = .532; 95% CI = 1.428, 
2.032). Knowledge of the PPACA was entered into the final stage of the model, and also added 
significantly to the predictive utility of the model, x2 (1, N=693) = 4.194, p<.05, demonstrating 
that knowledge of the PPACA was associated with utilization of preventive reproductive health 
service utilization after controlling for demographic factors and duration of insurance coverage. 
For every 1-unit increase in PPACA knowledge score, there was a 3.4% greater likelihood of 
receiving preventive reproductive health services (p<.05; b = .034; 95% CI = 1.001, 1.069).   
Table 7. 
Hierarchical logistic regression analysis predicting preventive reproductive health service use 
Step Variable OR CI B SE p 
1. Age (Years) .996 (.971, 1.023) -.004 .013 ns 
 Race (Whites as reference group) .909 (.606, 1.366) -.095 .207 ns 
 Education Level 1.099 (1.019, 1.248) .094 .065 <.05 
 FPL Standing (Income) 1.000 (1.000, 1.001) .000 .000 ns 
2. Insurance Duration 1.703 (1.428, 2.032) .532 .090 <.001 
3. PPACA Knowledge 1.034 (1.001, 1.069) .035 .017 <.05 
N=693 
ns = not significant 
 Hypothesis 3.  
A multinomial logistic regression was used to test the hypothesis that knowledge of the 
PPACA predicts an increased likelihood of LARC method use above health insurance coverage 
and demographic factors. Birth control method was entered into the model as a nominal outcome 
(0 = no birth control., 1 = non-hormonal methods, 2 = hormonal methods, 3 = LARC methods). 
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Demographic factors [i.e., age, race, education level, and income (as a percentage of the federal 
poverty level)], number of months with health insurance coverage, and knowledge of the 
PPACA were entered into the model. As in hypothesis 2, the variables in stages one and two 
have established relationships to the outcome (Culwell & Feinglass, 2007; Gostin, 2014; Mestad 
et al., 2011; Ricketts et al., 2014) and were controlled for in the model. This analysis was also 
restricted to women who were at risk for pregnancy.  
Age was the only significant predictor in the model, x2 (3, N=408) = 21.239, p<.001. This 
predictor was only significant when comparing those who did not use birth control in the 
previous year to those who used a hormonal method(s) during this time. The analysis showed 
that as age increased, the odds of using a hormonal method of birth control decreased (Table 8). 
The other demographic factors of race, x2 (3, N=408) = 1.084, p=.781, education, x2 (3, N=408) 
= 1.985, p=.576, and federal poverty adjusted income, x2 (3, N=408) = 7.241, p=.065. The 
duration of insurance coverage during the previous year was also not a significant predictor, x2 
(3, N=408) = 3.122, p=.373. Finally, knowledge about the PPACA was not a significant 
predictor, x2 (3, N=408) = 3.809, p=.283. 
Table 8. 
Multinomial logistic regression predicting use of various birth control methods 
 Non-hormonal method, 
last year (n = 235) 
Hormonal method, 
last year (n = 201) 
LARC method, 
last year (n = 86) 
 OR 95% CI OR 95% CI OR 95% CI 
Age 1.002 (.945, 1.063) .926* (.871, .984) .941 (.881, 1.006) 
Race (White as 
reference group) 
.998 (.796, 1.252) 1.101 (.872, 1.390) 1.045 (.810, 1.347) 
Education .883 (.577, 1.352) 1.089 (.693, 1.711) 1.116 (.673, 1.851) 
Insurance duration 1.000 (.999, 1.001) 1.001 (1.000, 1.002) 1.001 (1.000, 1.002) 
FPL standing (Income) 1.019 (.944, 1.100) 1.055 (.977, 1.139) 1.044 (.961, 1.134) 
PPACA knowledge .882 (.332, 2.339) .719 (.272, 1.901) .949 (.325, 2.769) 
N = 480 
None/ no birth control method used during previous year used as reference group 
*p<.05 
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Exploratory Analyses 
Because the results for hypothesis 3 showed that knowledge of the PPACA was not a 
significant predictor of contraceptive use, an exploratory analysis was conducted to evaluate 
other potential predictors. One of the predictors that was added into the model and evaluated was 
knowledge about birth control methods and use. It stands to reason that knowledge about birth 
control may be more influential than knowledge about the PPACA when making decisions about 
which method of birth control – if any – is appropriate for an individual woman. This claim is 
supported by previous research that has shown that low levels of awareness and understanding 
about LARC methods of birth control serve as a significant barrier to use (Dodson et al., 2012; 
Teal & Romer, 2013).  
Another predictor that was evaluated was the receipt of birth control counseling. This is 
thought to be related to birth control knowledge, as it serves as a vehicle through which 
clinicians can provide accurate information about contraception. Birth control counseling 
services focus on the education of the patient about the options available, and aiding them in 
choosing the method that works well for them after factoring in their concerns. Part of this 
process may also aid the patient in navigating insurance coverage and benefits when cost is a 
concern. 
A final predictor evaluated was pap smear receipt during the previous 3 years. It may be 
that going to the doctor to receive a pap smear creates an additional opportunity to receive 
contraceptive services, especially considering that a common component of doctor’s visits for 
pap smears is a discussion about contraceptive use and methods. Consistent with this idea, Pourat 
and colleagues (2008) found that receiving a pap smear increased the likelihood that women 
would receive Chlamydia screening and other studies have found that higher rates of doctor’s 
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visits result in more positive health outcomes (Baicker, Taubman, & Allen, 2013; Sommers, 
Long, & Baicker, 2014). Furthermore, literature shows that many clinicians still require pelvic 
exams and pap smears before they will prescribe oral contraception, which further establishes the 
link between the two services (Henderson, Sawaya, Blum, Stratton, & Harper, 2010).   
For this analysis, the outcome variable was divided into the same 4 categories: (0) None/ 
no birth control (n = 32), (1) Non-hormonal (n = 162), (2) Hormonal (n = 166), and (3) LARC (n 
= 72). The overall model was significant, x2 (24, N = 480) = 159.875, p<.001, and the 
Nagelkerke pseudo R2 suggested that the predictors in the model accounted for approximately 
33.8% of the total variance in method of birth control used during the previous year.  Knowledge 
of the PPACA was removed from this model, and birth control knowledge, pap smear receipt, 
and birth control counseling were entered in (Table 9).  
 Birth control knowledge significantly added to the predictive utility of the model, x2 (3, N 
= 480) = 44.886, p<.001, and suggested that for every 1 unit increase in birth control knowledge 
scores, there was a 25.2% greater likelihood of using a hormonal birth control method (p <.01; b 
= .225; 95% CI = 1.086, 1.444), and a 57.2% greater likelihood of using a LARC method of birth 
control (p<.001; b = .452; 95% CI = 1.331, 1.856), although it was not a significant predictor for 
non-hormonal birth control use. 
 Pap smear receipt during the previous 3 years was also a significant predictor, x2 (3, N = 
480) = 13.638, p<.01, and showed that those who had received a pap smear during the previous 3 
years were 2.7 times more likely to use a hormonal method of birth control (p<.05; b = 1.006; 
95% CI = 1.068, 7.000), and 5.7 times more likely to use a LARC method of contraception 
(p<.01; b = 1.745; 95% CI = 1.723, 19.023). Pap smear receipt was not a significant predictor of 
non-hormonal birth control use.  
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 Birth control counseling during the previous year also added to the predictive utility of 
the model, x2 (3, N = 480) = 40.283, p<.001, and indicated that those who had received birth 
control counseling during the previous year were 8.7 times more likely to have used a hormonal 
method of birth control (p<.01; b = 2.163; 95% CI = 2.416, 31.332), and 4.1 times more likely to 
have used a LARC method for birth control (p<.05; b = 1.411; 95% CI = 1.059, 15.863). Birth 
control counseling during the previous year was not, however, a significant predictor of non-
hormonal contraceptive use during the last year. 
Table 9. 
Multinomial logistic regression predicting use of various birth control methods 
 Non-hormonal 
method, last year 
(n = 235) 
Hormonal 
method, last 
year (n = 201) 
LARC method, last 
year                         
(n = 86) 
 OR 95% CI OR 95% CI      OR 95% CI 
Age 1.001 (.944, 1.061) .942 (.883, 1.004) .935 (.870, 1.005) 
Race (White as 
reference group) 
1.381 (.497, 3.838) 2.140 (.740, 6.187) 1.966 (.608, 6.356) 
Education .971 (.769, 1.226) 1.029 (.801, 1.322) .956 (.727, 1.258) 
FPL standing (Income) 1.000 (.999, 1.001) 1.001 (1.000, 1.002) 1.001 (1.000, 1.002) 
Insurance Duration .795 (.512, 1.237) .846 (.517, 1.386) .835 (.476, 1.466) 
Birth control knowledge 1.117 (.978, 1.276) 1.252** (1.086, 1.444) 1.572*** (1.331, 1.856) 
Birth control counseling 1.369 (.586, 3.196) 2.734* (1.068, 7.000) 5.725** (1.723, 19.023) 
Pap test, last 3 years 1.780 (.485, 6.540) 8.701** (2.416, 31.332) 4.099* (1.059, 15.863) 
N = 480 
None/ no birth control method used during previous year used as reference group 
*p<.05; **p<.01; ***p<.001 
 
Discussion 
 The present study was the first to evaluate the role of PPACA knowledge in preventive 
sexual and reproductive health service utilization among women. Results from this study further 
the understanding of some of the factors that contribute to female use of preventive reproductive 
health services, and highlight the fact that expanding access to health insurance coverage is just 
one component necessary to increase utilization of preventive services.   
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Hypothesis 1a 
 The PPACA set out to increase access to services among women by reducing the cost 
barrier for services in two ways: (1) increasing access to affordable insurance coverage, and (2) 
mandating that this insurance coverage consider women’s reproductive preventive care and 
cover it with no cost-sharing responsibilities for the woman. The first hypothesis examined 
variations in preventive reproductive health service use based on duration of insurance coverage. 
Findings show that possession of insurance for any duration of time throughout the year is 
associated with higher rates of participation in cancer screening services, STI testing, and birth 
control counseling among women. These findings provide support for existing literature that has 
established lack of health insurance coverage and shorter duration of coverage as barriers to 
service use among women (Garfield et al., 2014; Geisler, 2006; Kaiser Commission of Medicaid 
and the Uninsured, 2006; Rodriguez et al., 2005). 
Furthermore, findings provide support for the methods utilized by the PPACA, and show 
that having insurance that covers preventive health services is associated with higher rates of 
utilization for various preventive services that are extremely important for women to receive. 
This finding suggests that there would likely be value in the expansion of Medicaid in states that 
have not already made this change, especially when considering that two-thirds of the 6.4 million 
adults that are uninsured due to lack of expansion are women. Access to insurance coverage 
under Medicaid would allow these women to access valuable preventive reproductive health 
services in an affordable way, thus meeting many of their health needs and improving their 
health outcomes. Providing such coverage and access to preventive health services may also 
provide a financial benefit to states by eliminating costs related to treatment of conditions, such 
as the $16 billion that is spent annually in the U.S. on direct medical costs related to STIs.  
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Hypothesis 1b 
 Differences in LARC method use was also evaluated in relation to duration of health 
insurance coverage. Findings from the current study indicated that there were not significant 
differences in LARC method use based on duration of coverage. A subsequent analysis also 
revealed that there were no significant differences in the use of any hormonal form of birth control 
based on duration of coverage. These findings contradict those of previous studies, which have 
found that those without insurance are less likely to utilize prescription contraception, and that cost 
is one of the most significant barriers to the adoption of LARC methods (Culwell & Feinglass, 
2007; Gostin, 2014; Guttmacher Institute, 2014; Piepert et al., 2012; Ricketts et al., 2014).   
 These findings may indicate that possession of insurance coverage is not enough to 
guarantee utilization of services, and that there are other influential factors that need to be 
targeted if increased utilization of LARC methods is desired in the U.S. One such factor may be 
the type of insurance plans that women possess. Although the provision of other preventive 
health services is well-established and largely standardized across carriers and policies, 
contraception is still somewhat separated from the other services and may be covered differently 
depending on carrier or plan type. This may mean that not all women are actually guaranteed 
comprehensive access to contraception as originally intended by the PPACA.  
Research by the Kaiser Family Foundation on contraceptive coverage provided by 
different carriers in five U.S. states found that the interpretation of the contraceptive mandate and 
its accompanying guidelines was not uniform across carriers. Although the CDC suggests that 
carriers provide coverage for the full range of FDA-approved contraceptive methods, it is not 
required and issuers are permitted to use reasonable medical management (RMM) to control 
costs (Sobel, Salganicoff, & Kurani, 2015). There are no specific guidelines for how RMM 
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should be implemented, though, and some carriers have used this as a loophole to avoid 
providing coverage for certain contraceptive methods.  
In practice, these RMMs can appear in a few different forms. One type of RMM is 
chemical compound limitation, wherein carriers decide to provide coverage without cost-sharing 
for only one of the methods that are chemically equal, regardless of different delivery systems. 
This means that carriers can decide to cover oral contraception and refuse to cover the patch or 
ring (which are often more expensive), or cover IUD’s and refuse to cover implants, because 
they contain the same chemical compounds (Sobel et al., 2015). Another RMM is step therapy, 
where carriers require patients to try lower tier (usually lower-cost) methods before moving up to 
the next tier. This requires that patients try lower tier methods, and have a provider document 
that these methods were not successful and a higher tier method is medically necessary (Sobel, et 
al., 2015). A final method of RMM is requiring that approval be obtained from the insurance 
carrier beforehand, so that the service or medication prescribed by the provider will be covered 
later. These RMMs are not used by all carriers or present in all plans; however, they do have the 
ability to create inequality in contraceptive access for women who do possess these plans. 
Hypothesis 2 
 The second hypothesis was to examine the influence of PPACA knowledge on preventive 
service utilization, after controlling for demographic factors and duration of health insurance 
coverage. A study conducted by Gross and colleagues (2012) found that those who knew more 
about the PPACA held more favorable attitudes towards the legislation, and suggested that 
increasing knowledge about the legislation may result in considerably higher rates of approval. 
Present findings suggest that increasing knowledge about the legislation would also result in 
higher rates of preventive reproductive health service utilization among women. Specifically, for 
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each 1-unit increase in knowledge about the PPACA, the likelihood of preventive service use 
rose 3.5%.  
 This finding supports the importance of the outreach efforts that were built into the 
healthcare legislation. However, participant PPACA knowledge scores for the current study also 
show that accurate knowledge of the legislation in still very low. The average number of correct 
responses provided was 6 out of 31 when level of certainty about the response was taken into 
consideration, which is perhaps more alarming when considering that, overall, the sample was 
highly educated. Previous work has shown that those with less education understand less about 
the changes implemented by the PPACA (Gross et al., 2012; Hall et al., 2014), which would 
suggest that knowledge would likely be even lower among the general population.  
 Results also showed that those with higher levels of educational attainment were more 
likely to engage in preventive service use. This echoes findings from previous studies that show 
that those who are more educated are more likely to use reproductive health services (Hall et al., 
2014; Hall, Dalton, & Johnson, 2014; McMorrow et al., 2014). The association between these 
factors and preventive reproductive service use may offer support for intervention efforts 
delivered at the community level that are targeted toward those with lower educational 
attainment and those with less access to accurate information about the healthcare law. Since the 
legislation includes provisions and funding for enhancing outreach and enrollment, it would be 
beneficial to ensure that those efforts and funds are heavily concentrated in communities that 
possess lower rates of education to maximize rates of service utilization. 
Additionally, duration of health insurance coverage during the previous year was a 
significant predictor of preventive service use, with those who had possessed insurance coverage 
for a longer period of time throughout the year being more likely to have utilized preventive 
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health services. As previously stated for hypothesis 1a, this finding supports the existing 
literature (Culwell & Feinglass, 2007; Gostin, 2014; Guttmacher Institute, 2014; McMorrow et 
al., 2014; Piepert et al., 2012; Ricketts et al., 2014), as well as the efforts of the PPACA to 
increase access to insurance coverage and efforts to persuade the remaining 19 U.S. states to 
expand Medicaid coverage.   
However, it is also important to note that while insurance coverage was shown to 
influence service use, just over 75% of the sample had insurance coverage for all 12 months of 
the year, and rates of use for some services, such as breast exams (47%), birth control counseling 
(30%) and STI testing (25%) were still somewhat low. Rates of receipt for these services were 
also much lower than having had a well woman’s visit or physical (64%) during the same time 
period. It is also worth noting that approximately 23% of the women who were insured for all 12 
months of the previous year had not obtained a pap smear within the previous 3 years. Pap 
smears are an important aspect of women’s health and prevention of severe negative health 
outcomes, making receipt of this service very important. As exploratory analyses showed, pap 
smear receipt may also be an important factor when considering the adoption of more effective 
contraceptive methods. Understanding that women who had insurance coverage during the 
previous year had access to this preventive service and still did not obtain it may be cause for 
concern, and is worth exploring in future research.  
To an extent, the aforementioned rates of service use may reflect the diversity of needs 
among women in the sample as they age, marry, have children, etc. Still, this may also reflect 
sentiments expressed in previous research that visiting a provider does not guarantee that a 
patient will receive all of the recommended services (Howell & Kenney, 2012). While the 
present study did not intend to directly assess this issue, some of the items used can still offer 
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insight. Of the 708 participants in the current sample, 66% said that they would likely get tested 
for STIs if the service was offered for free by their provider, and 65% reported that a provider 
had never (in the participant’s lifetime) suggested that they receive STI testing. These rates may 
indicate a disconnect in patient/ provider communication and unsuccessful attempts to offer 
comprehensive preventive care. These are issues that could be addressed through the expansion 
of initiatives such as provider training in assessment and communication, providing support and 
resources to providers’ offices that is designed to educate patients about health risks and 
available services, or encouraging pay-for-performance programs for providers.  
Hypothesis 3 
 The third hypothesis evaluated the role of PPACA knowledge on the use of LARC 
methods, after controlling for demographic factors and duration of health insurance coverage. A 
recent study on LARC adoption showed that when cost was removed as a barrier, 70-75% chose 
to use LARC methods (Mestad et al., 2011; Peipert et al., 2012). Because the PPACA mandated 
the provision of contraception coverage without cost-sharing in (almost) all insurance policies, it 
was expected that those who had more knowledge of the healthcare legislation would adopt 
LARC methods at a higher rate. However, results from this sample did not support this 
hypothesis. Knowledge of the PPACA also did not predict higher rates of non-hormonal or 
hormonal birth control use.  
 As previously stated, this may partly be due to the differences in interpretation of the 
PPACA’s contraceptive coverage mandate that has resulted in a lack of standardization of 
contraception coverage among carriers and plans, as well as difficulties accessing and 
deciphering such coverage information. Because these actions have the ability to directly inhibit 
a woman’s ability to choose the method that is best for her, it would be advantageous to work on 
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progressing legislation mirroring California’s ‘Contraceptive Coverage Equity Act of 2014.’ 
This law mandates coverage of methods that have been FDA-approved, requires that at least one 
option of equivalent contraceptives be covered with no cost-sharing responsibilities for the 
insured, and defines equivalent contraceptives as those with the same chemical formulation and 
delivery system (Sobel et al., 2015).  
 This finding may also indicate the need to increase LARC knowledge and training among 
providers. Some studies have indicated that providers often fail to consider nulliparous women as 
appropriate candidates for IUDs, many lack training, and not all women’s health facilities offer 
LARC services (Kavanaugh, Carlin, & Jones, 2011; Kavanaugh, Jones, & Finer, 2010). Thus, 
measures may be necessary to increase provider awareness and education before issues about 
awareness and education of potential patients can be addressed. 
Exploratory Analyses 
 An exploratory analysis was performed to evaluate factors other than knowledge of the 
PPACA that may predict utilization of various methods of contraception. Birth control 
knowledge, birth control counseling, and pap smear receipt were all significant predictors of the 
utilization of LARC methods, as well as hormonal birth control use. Those who had higher rates 
of knowledge of birth control methods and use were more likely to use a hormonal or LARC 
method of birth control over no method of contraception than those who had lower levels of 
knowledge, which supports findings from previous work (Dodson et al., 2012; Frost, Lindberg, 
& Finer, 2012; Teal & Romer, 2013).  
This finding also lends support for continued (and perhaps expanded) funding for state 
and community programs aimed at increasing reproductive health knowledge. More 
immediately, it also suggests that support should be provided for President Obama’s suggestion 
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to eliminate funding for abstinence-only sexual education programs and instead allot those funds 
toward evidence-based education programs instead. A necessity for the development and 
maintenance of programs that reduce contraceptive costs for low-income women or women with 
poor insurance coverage may be highlighted as well. It was previously assumed that such 
programs would become obsolete following implementation of the PPACA; however, with 
evidence present that the contraceptive mandate is not being followed as it was intended and 19 
states still not yet expanding Medicaid coverage to their residents, they are likely still valuable 
for many.  
Moreover, those who had received birth control counseling during the previous year were 
almost 3 times more likely to have used a hormonal method and almost 6 times more likely to 
have used a LARC method of birth control. These findings support those of previous research, 
which have shown that low levels of awareness and knowledge about LARC methods serve as a 
significant barrier to adoption (Dodson et al., 2012; Teal & Romer, 2013). These findings also 
offer room for optimism, since birth control counseling is considered an essential health benefit 
to be covered without cost-sharing. Also, although differences exist in contraceptive coverage for 
some carriers or plans, Sobel and colleagues (2015) found that coverage for contraceptive 
counseling is uniformly provided. It is possible that these changes will result in a natural 
progression toward the use of the more effective LARC methods of contraception among women 
in the U.S. as the provision of counseling services continues to increase. This will, however, 
require that providers take some initiative in advertising this service to their patients and 
incorporating it into comprehensive health visits.  
 Additionally, those who had received a pap smear in the previous three years were over 
eight times more likely to have reported using a hormonal method of birth control, and four 
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times more likely to have reported LARC use. This finding is consistent with those of other 
studies that have found that receiving a pap smear increased the likelihood of a woman receiving 
Chlamydia screening (Pourat et al., 2008), and that higher rates of doctor’s visits are related to 
better health outcomes (Baicker et al., 2013; Sommers et al., 2014). This finding may provide 
additional support for the need to integrate the various reproductive health services into 
comprehensive visits. If the specific goal is to increase the use of the most effective 
contraceptive methods, then it may be most beneficial for providers to provide pap screening, 
contraceptive counseling, and birth control prescription or medical services as a single visit. 
Limitations 
 Despite overall support for some hypotheses, several limitations must be considered. One 
limitation was the use of a cross-sectional correlational design, which prevents drawing any 
causal inferences. This study also employed a relatively small sample size, which was reduced 
yet again when analyses required the exclusion of those who were not at risk for pregnancy. In 
particular, only a very small subset of the sample reported using LARC methods of birth control.  
 The sample was also majority white (76.7%), and highly educated, with more than 70% 
having received education beyond high school. This may reduce the ability to generalize beyond 
these groups. The demographic distribution is likely a byproduct of internet sampling, which 
tends to result in such samples. Relying on self-reports of health behaviors and service receipt, 
which are likely to contain some measurement error, is also a limitation of the present study. 
Participants may not be able to accurately recall the frequency or timing of participation in health 
services, or may feel pressure to report receiving recommended preventive reproductive health 
services (Bhandari & Wagner, 2006).  
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 Sampling bias is also a limitation of this study. Although Amazon Mechanical Turk has 
the ability to recruit a nationally representative sample, individuals are still in control of which 
studies they self-select into. It is possible that those who decided to self-select into a study about 
health and the healthcare legislation differ from the general population. 
 This study also did not assess attitudes towards the surveyed preventive health services, 
perceptions of health risk, or attitudes toward medical professionals or organizations. Previous 
research has shown that lacking trust in medical providers or services is a barrier to utilization 
(Issac, Brandon, LaVeist, 2005; Thornburn & Bogart, 2005). This may be particularly true 
among populations that are often the “targets” of health promotion and intervention programs, 
such as young women, racial and sexual minorities, and those with lower incomes and education 
levels (Gilliam, 2015; Gold, 2014; Gomez, Fuentes, & Allina, 2014; Higgins, 2014; Johnson & 
Nemeth, 2014). Studies have also shown that individuals tend to feel uncomfortable or 
embarrassed during reproductive health care screenings or may anticipate pain, and may choose 
to avoid them altogether as a result (Fiddles, Scott, Fletcher, & Glasier, 2003; Kahn et al., 1999). 
Future studies should incorporate health risk perceptions, attitudes toward health services and 
providers, and provider discrimination in models of health care coverage and service receipt after 
the PPACA.  
General Implications 
 While using self-report data is a limitation of this study, online surveying resulted in a 
geographically representative national sample of women and provided insight into some of the 
factors that predict the use of preventive reproductive services. An implication of the present 
study is that expanding knowledge about the PPACA may be beneficial in increasing the 
utilization of preventive reproductive health services among women, generally. The current 
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findings provide support for an increase in funds and resources to outreach and education of the 
general population about the provisions and benefits of the PPACA, as well as individuals’ 
personal health coverage plans.  
However, the present research also suggests that increasing knowledge of the healthcare 
legislation may not be as influential in increasing the rates of adoption for more effective 
contraceptive methods (i.e., hormonal and LARC methods in place of non-hormonal methods 
and non-use of contraception). Instead, knowledge about birth control use and methods, and 
receipt of contraceptive counseling and pap smears are stronger predictors of such contraceptive 
use. This would suggest that increasing outreach and educational efforts focused on hormonal 
birth control and LARCs as options in the general population may be more beneficial in 
increasing adoption of these contraceptive methods.  
Additionally, the current study provides support for the necessity of provider education 
and training for LARC methods, and suggests continued focus on improving patient/ provider 
communication and developing truly comprehensive, patient-centered reproductive healthcare 
for women. Findings may highlight a disconnect between the intentions of the PPACA’s 
contraceptive mandate and the actual implementation of such benefits. Policy efforts are 
encouraged to address the improper utilization of RMMs in contraceptive coverage by insurance 
carriers, in addition to the lack of informational transparency of these benefits. Such efforts have 
the potential to improve access to more effective contraceptive methods for women by 
standardizing coverage across carriers and ensuring that women are able to use the contraceptive 
method of her choice without cost barriers.   
 48 
 
References 
 
American Cancer Society. (2015). Testicular Cancer. Retrieved from: http://www.cancer.org/acs/ 
groups/content/@nho/documents/document/testicularcancerpdf.pdf 
 
Azzam, T., Jacboson, M. R. (2013). Finding a comparison group: Is online crowdsourcing a 
viable option? American Journal of Evaluation, 34(3), 372-384.  
 
Baicker, K., Taubman, S. L., Allen, H. L. (2013) The Oregon experiment: Effects of Medicaid 
on clinical outcomes. The New England Journal of Medicine. 368(18), 1713-1722. 
 
Bartneck, C., Duenser, A., Moltchanova, E., & Zawieska. (2015). Comparing the similarity of 
responses received from studies in Amazon’s Mechanical Turk to studies conducted 
online and with direct recruitment. PLoS ONE, 10(4): e0121595. 
doi:10.1371/journal.pone.0121595 
 
Berinsky, A. J., Huber, G. A., Lenz, G. S. (2012). Evaluating online labor markets for 
experimental research: Amazon.com’s Mechanical Turk.  Political Analysis, 20, 351-368. 
 
Breastcancer.org (2015). U.S. breast cancer statistics. Retrieved from: 
http://www.breastcancer.org/symptoms/understand_bc/statistics 
 
Bhandari, A., Wagner, T. (2006). Self-reported utilization of health care services: Improving 
measurement and accuracy. Medical Care Research and Review, 63(2), 217 – 235. 
 
Brewer, N. T., Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-
informed, systematic review. Preventive medicine, 45 (2-3), 107-114. 
 
Brill, S. (2013). Bitter pill: Why medical bills are killing us. Time Magazine. Retrieved from: http: 
//www.uta.edu/faculty/story/2311/Misc/2013,2,26,MedicalCostsDemandAndGreed.pdf 
 
Buettgens M, Garrett AB, Holahan J. America Under the Affordable Care Act. Washington, DC: 
Urban Institute; 2010. 
 
Buhrmester M, Kwang T, Gosling SD (2011). Amazon’s Mechanical Turk: A New Source of 
Inexpensive, Yet High-Quality, Data? Perspectives in Psychological Science, 6: 3–5. 
 
Burke  SC,  Vail-Smith  K,  White  DM,  Baker  E,  Mitchelle T. Getting vaccinated against 
HPV: attitudes, intentions, and perceived barriers of female undergraduates. Coll Stud J. 
2010;44:55–64. 
 
 49 
 
Bynum SA, Wright MS, Brandt HM, Burgis JT, Bacon JL. Knowledge, beliefs, and attitudes 
related to human papillomavirus infection and vaccination, pap tests, and cervical 
intraepithelial neoplasia among adolescent girls and young women. J S C Med Assoc. 
2009;105:267–272. 
 
Centers for Disease Control and Prevention. (2013). Incidence, prevalence, and cost of 
sexually transmitted infection in the United States. Retrieved from: 
http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf. 
 
Centers for Disease Control and Prevention. (2014). Cervical cancer statistics. Retrieved from: 
http://www.cdc.gov/cancer/cervical/statistics/index.htm 
 
Centers for Disease Control and Prevention. (2014). Prostate cancer statistics. Retrieved from: 
http://www.cdc.gov/cancer/prostate/statistics/index.htm 
 
Centers for Disease Control and Prevention. (2014). Uterine cancer statistics. Retrieved from: 
http://www.cdc.gov/cancer/uterine/statistics/index.htm 
 
Chabot, M., Lewis, C., Thiel de Bocanegra, H., & Darney, P. (2011). Correlates of receiving 
reproductive health care services among U.S. men aged 15 to 44 years. American Journal 
of Men's Health, 5(4), 358-366. 
 
Champion, V. L., Skinner, C. S. (2016). The health belief model. Health Behavior and Health 
Education: Theory, Research, and Practice, 4th edition. 
 
Cohen, T. (2013). Human papillomavirus: Identifying vaccination rates, barriers, and 
information gathering among college women ages 18-26. Virginia Commonwealth 
University. 1-166. 
 
Collins, S., Rustgi, S., & Doty, M. (2010). Realizing health reform’s potential: Women and 
the Affordable Care Act of 2010. The Commonwealth Fund. 
 
Conner, M. & Norman, P. (1996). Predicting Health Behavior. Search and Practice with Social 
Cognition Models. Open University Press: Ballmore: Buckingham. 
 
Conroy, K., Rosenthal, S. L., Zimet, G. D., Jin, Y., Bernstein, D. I., Glunn, S., Kahn, J. A. 
(2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-
reported barriers to vaccination. Journal of Women’s Health. 18, 1679-1686. 
 
 50 
 
Crissey, S. R. (2005). Effect of pregnancy intention on child well-being and development: 
Combining retrospective reports of attitude and contraceptive use. Popul Res Policy Rev 
24:593–615 
 
Crump, M. J. C., McDonnell, J. V., Gureckis, T. M. (2013). Evaluating Amazon’s Mechanical 
Turk as a tool for experimental behavioral research. Public Library of Science One, 8(3), 
1-18.  
 
Culwell, K. R., & Feinglass, J. (2007). The association of health insurance with use of 
prescription contraception.  Perspectives on Sexual and Reproductive Health. 39, 226-
230. 
 
Dodson, N. A., Gray, S. H., Burke, P. J. (2012). Teen pregnancy prevention on a LARC: An 
update on long-acting reversible contraception for the primary care provider. Current 
Opinion in Pediatrics, 24(4), 439-45.  
 
Doty, M., Blumenthal, D., & Collins, S. (2014). The Affordable Care Act and health insurance 
for Latinos. JAMA, 312(17), 1735-6. 
 
East, P. L., N. C. Chien, and J. S. Barber. 2012. Adolescents’ pregnancy intentions, wantedness, 
and regret: Cross-lagged relations with mental health and harsh parenting. J Marriage 
Fam 74:167–85. 
 
Eisenberg, D. L., Secure, G. M., Madden, T. E., Allsworth, J. E., Zhao, Q., Peipert, J. F. (2012). 
Knowledge of contraceptive effectiveness. American Journal of Obstetrics and 
Gynecology, 206(479), e1-9. 
 
Fawcus, S. R. (2007). Maternal mortality and unsafe abortion. Best Practice & Research Clinical 
Obstetrics and Gynecology. 22(3) 533-548. Journal of Pakistan Medical Association, 
65(5), 452-456. 
 
Fiddles, P., Scott, A., Fletcher, J., Glasier, A. (2003). Attitudes toward pelvic examination and 
chaperones: A questionnaire survey of patients and providers. Contraception, 67, 313 – 
317. 
 
Finer, L. B., Zolna, M. R. (2016). Declines in unintended pregnancy in the United States, 2008-
2011. The New England Journal of Medicine, 374(9), 843 – 852. 
 
Fitzgerald, T., Cohen, L., Hyams, T., Sullivan, K. M., Johnson, P. A. (2014). Women and health 
reform: How national health care can enhance coverage, affordability, and access for 
women (examples from Massachusetts). Women's Health Issues, 24(1), e5-e10.  
 51 
 
 
Frost, J. J. (2013). U.S. women's use of sexual and reproductive health services: Trends, sources 
of care, and factors associated with use, 1995 - 2010. New York: The Alan Guttmacher 
Institute.  
 
Frost, J. J., Lindberg, L. D., Finer, L. B. (2012). Young adults’ contraceptive knowledge, norms 
and attitudes: Associations with risk of unintended pregnancy. Perspectives on Sexual 
and Reproductive Health, 44(2), 107 – 116. 
 
Garfield, R., Licata, R., & Young, K. (2014). The uninsured at the starting line: Findings from 
the 2013 Kaiser survey of low- income Americans and the ACA. Kaiser Family 
Foundation. 
 
Geisler, W., Chyu, L., Kusunoki, Y., Upchurch, D., & Hook, E. (2006). Health insurance  
 coverage, health care-seeking behaviors, and genital chlamydial infection prevalence in  
 sexually active young adults. Sexually Transmitted Diseases, 33(6), 389-96. 
 
Giambi, C., Donati, S., Declich, S., Salmaso, S., Degli, A., Marta, L., Alibrandi, M. (2011). 
Estimated acceptance of HPV vaccination among Italian women aged 18–26 years. 
Vaccine, 29(46), 8373-8380. 
 
Gilliam, M L. (2015). Beyond coercion: Let us grapple with bias. Obstetrics & Gynecology, 
126(5), 915 - 916. 
 
Glanz, K., Rimer, B.K. & Lewis, F.M. (2002). Health Behavior and Health Education. Theory, 
Research and Practice. San Francisco: Wiley & Sons. 
 
Gold RB, Sonfield A. Publicly funded contraceptive care: a proven investment. Contraception 
2011;84:437–9. 
 
Gold, R. B. (2014). Guarding against coercion while ensuring access: A delicate balance. 
Guttmacher Policy Review, 17, 8 – 14. 
 
Gomez, A. M., Fuentes, I., Allina, A. (2014). Women or LARC first? Reproductive autonomy 
and the promotion of long-acting reversible contraceptive methods. Perspectives on 
Sexual and Reproductive Health, 46, 171 – 175. 
 
Goodwin, S. M., Anderson, G. F. (2012). Effect of cost-sharing reductions on preventive service 
use among Medicare fee-for-service beneficiaries. Centers for Medicare & Medicaid 
Services, Center for Strategic Planning, 2(1),  doi: 
http://dx.doi.org/10.5600/mmrr.002.01.a03 
 52 
 
 
Gostin, L. (2014). The ACA's contraceptive mandate: Religious freedom, women's health, and 
corporate personhood. JAMA, 312(8), 785-6.        
 
Gross, W., Stark, T. H., Krosnick, J., Pasek, J., Gaurav, S., Tompson, T., Agiesta, J., Junius, D. 
(2012). Americans’ attitudes toward The Affordable Care Act: Would better public 
understanding increase or decrease favorability? Princeton, NJ: Robert Wood Johnson 
Foundation Inc. 
 
Hall, K., Fendrick, A., Zochowski, M., & Dalton, V. (2014). Women's health and the Affordable 
Care Act: High hopes versus harsh realities? American Journal of Public Health, 104(8), 
E10-3. 
 
Hamel, L., Norton, M., Levitt, L., Claxton, C., Pollitz, K, et al., (2014) Survey of non-group 
health insurance enrollees. Retrieved from Kaiser Family Foundation: 
http://kff.org/health-reform/report/survey-of-non-group-health-inssurance-enrollees/ 
 
Heer J, BostockM (2010) Crowdsourcing graphical perception: using mechanical turk to assess 
visualization design. In: Proceedings of the SIGCHI Conference on Human Factors in 
Computing Systems. New York, NY, USA: ACM, CHI’10, pp. 203–212. URL 
http://doi.acm.org/10.1145/1753326.1753357.  
 
Henderson, J. T., Sawaya, G. F., Blum, M., Stratton, L. Harper, C. C. (2010). Pelvic 
examinations and access to oral hormonal contraception. Journal of Obstetrics and 
Gynecology, 116 (6), 1257-1264. 
 
Higgins, J. A. (2014). Celebration meets caution: LARC’s boons, potential busts, and the 
benefits of a reproductive justice approach. Contraception, 89, 237 – 41. 
 
Hochbaum, G. M. (1958). Public participation in medical screening programs: A 
sociopsychological study. (Public Health Service, PHS Publication 572). Washington, 
DC: U. S. Government Printing Office. 
 
Holguin, A. C. (2010). Determining the knowledge and attitudes of 18- to 26- year old women 
regarding cervical cancer, human papillomavirus, and the human papillomavirus 
vaccine. Retrieved from: 
http://digitalcommons.usu.edu/cgi/viewcontent.cgi?article=1467 &context=etd. 
 
Hollander, D. (2006). Young Adults Who Lack Continuous Health Insurance Coverage Have an  
 Elevated Risk of Chlamydia Infection. Perspectives on Sexual and Reproductive 
Health, 38(4), 229-230. 
 
 53 
 
Howell, E. M., Kenney, G. (2012). The impact of Medicaid/ CHIP expansions on children. 
Medical Care Research and Review, 69(4), 372 – 396. 
 
Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy 
Outcomes; Behrman RE, Butler AS, editors. (2007). Preterm Birth: Causes, 
Consequences, and Prevention. Washington (DC): National Academies Press 
(US); Available from: http://www.ncbi.nlm.nih.gov/books/NBK11362/ 
 
Issac, L. A., Brandon, D. T., LaVeist, T. A. (2005). The legacy of Tuskegee and trust in 
medical care: Is Tuskegee responsible for race differences in mistrust of medical care? 
Journal of the National Medical Association, 97, 951 – 956. 
 
Janz, N. K., Becker, M. H. (1984). The health belief model: A decade later. Health Education 
Quarterly, 11(1), 1-47. 
 
Jaworski, B. C., & Carey, M. P. (2007). Development and Psychometric Evaluation of a Self-
administered Questionnaire to Measure Knowledge of Sexually Transmitted Diseases. 
AIDS and Behavior, 11, 557-574. 
 
Johnson, M. J., Nemeth, L. S. (2014). Addressing health disparities of lesbian and bisexual 
women: A grounded theory study. Women’s Health Issues, 24(6), 635 – 640. 
 
Jones, R. K., & Dreweke, J. (2011) Countering Conventional Wisdom: New Evidence on 
Religion and Contraceptive Use, New York: Guttmacher Institute. 
 
Jones, R. K.,& Ferman, J. (2014). Abortion Incidence and Service Availability in the United 
States, 2011. Perspectives on Sexual and Reproductive Health, 46(1), 3-11. 
 
Jones, R. K., Kavanaugh, M. L. (2011) Changes in abortion rates between 2000 and 2008 and 
lifetime incidence of abortion. Obstetrics & Gynecology, 117(6), 1358-1366. 
 
Jones, J., Mosher, W. D., & Daniels, K. (2012). Current contraceptive use in the United States 
2006-2010, and changes in patterns of use since 1995. National Health Statistics Reports, 
60. 
 
Kaestle, C. E., Waller, M. W. (2011). Bacterial STDs and perceived risk among sexual minority 
young adults. Perspectives in Sexual and Reproductive Health, 43(4), 158-163. 
 
Kahn, J. A., Chiou, V., Allen, J. D., Goodman, E., Perlman, S. E., Emans, S. J. (1999). Beliefs 
about Papanicolaou smears and compliance with Papanicolaou smear follow-up in 
adolescents. Archive of Pediatric Adolescent Medicine, 153, 1046 – 1054. 
 54 
 
 
Kaiser Commission on Medicaid and the Uninsured, (2006). The uninsured and their access to 
health care. Retrieved April 2011 from http://www.kff.org/uninsured. 
 
Kaiser Family Foundation. (2010). Births financed by Medicaid. Retrieved from: 
http://kff.org/medicaid/state-indicator/births-financed-by-medicaid/ 
 
Kaiser Family Foundation. (2012). Massachusetts health care reform: Six years later. 
Retrieved from: https://kaiserfamilyfoundation.files.wordpress.com/2013/01/8311.pdf. 
 
Kaiser Family Foundation. (2013). Health reform: Implications for women's access to coverage 
and care. Retrieved from: http://kff.org/womens-health-policy/issue-brief/health-reform-
implications-for-womens-access-to/ 
 
Kaiser Family Foundation. (2014). Key facts about the uninsured population. Retrieved from: 
http://kff.org/uninsured/fact-sheet/key-facts-about-the-uninsured-population/ 
 
Kaiser Family Foundation. (2015). Preventative services covered by private health plans 
under the Affordable Care Act. Retrieved from: http://kff.org/health-reform/fact-
sheet/preventive-services-covered-by-private-health-plans/ 
 
Kaiser Family Foundation (2015). Status of state action on the Medicaid expansion decision. 
Retrieved from: https://kaiserfamilyfoundation.files.wordpress.com/2015/07/current-
status-of-the-medicaid-expansion-decisions-healthreform2.png 
 
Kalmuss, D., Tatum, C. (2007) Patterns of men’s use of sexual and reproductive health 
services. Perspectives on Sexual and Reproductive Health. 39 (2). 74-81 
 
Kavanaugh, M. L., Carlin, E. E., Jones, R. K. (2011). Patients’ attitudes and experiences related 
to receiving contraception during abortion care. Contraception, 84(6), 585 – 593. 
 
Kavanaugh, M. L., Jones, R. K., Finer, L. B. (2010). How commonly do U.S. abortion clinics 
offer contraception? Contraception, 82, 331-336. 
 
Kavanaugh ML, Frohwirth, L., Jerman, J., Popkin, R., Ethier, K. Long-acting reversible 
contraception for adolescents and young adults: patient and provider perspectives, 
Journal of Pediatric and Adolescent Gynecology, 2013, 26(2):86–95. 
 
 55 
 
Kaye, K., Suellentrop, K., and Sloup, C. (2009). The Fog Zone: How Misperceptions, Magical 
Thinking, and Ambivalence Put Young Adults at Risk for Unplanned Pregnancy. 
Washington, DC: The National Campaign to Prevent Teen and Unplanned Pregnancy. 
 
Kessels, S., Marshall, H., Watson, M., Braunack-Mayer, A., Reuzel, R., Tooher, R. (2012). 
Factors associated with HPV vaccine uptake in teenage girls: A systematic review. 
Vaccine, 30(24), 3546-3556.  
 
Lurie, N., Manning, W. G., Peterson, C., Goldberg, G. A., Phelps, C. A., Lillard, L., (1987). 
Preventive care: Do we practice what we preach? American Journal of Public Health, 
77(7), 801-804. 
  
Maciosek, M. V., Coffield, A B., Edwards, N. M., Flottemesch, T. J., Goodman, M. J., Solberg, 
L. I. (2006). Priorities among effective clinical preventive services: Results of a 
systematic review and analysis. American Journal of Preventive Medicine, 31(1), 52-61. 
 
Markus, A. R., Andres, E., West, K. D., Garro, N., Pellegrini, C. (2013) Medicaid covered 
births, 2008 through 2010, in the context of the implementation of health reform. 
Women’s Health Issues. 23(5), e273 – e280. 
 
Martin, J. A., Hamilton, B. E., Osterman, M. J. K., Curtin, S. C., Mathews, T. J. (2013) Births: 
Final Data for 2012. National Vital Statistics Reports, 62 (9), 1-68. 
 
McMorrow, S., Kenney, G. M., & Goin, D. (2014). Determinants of receipt of recommended 
preventive services: Implications for the Affordable Care Act. American Journal of 
Public Health, 104(12), 2392-2399.  
 
Meltzer, C. (2011). Summary of the affordable care act. AJNR. American Journal of 
Neuroradiology, 32(7), 1165-6. 
 
Mestad, R., Secura, G., Allsworth, J. E., Madden, T., Zhao, Q., Peipert, J. F. (2011). 
Acceptance of long-acting reversible contraceptive methods by adolescent participants 
in the Contraceptive CHOICE Project. Contraception, 84(5), 493-498. 
 
Miller, W. B., M. R. Sable, and J. J. Beckmeyer. 2009. Preconception motivation and 
pregnancy wantedness: Pathways to toddler attachment security. J Marriage Fam 
71:1174–92. 
 
Monte, l. M., Ellis, R. R. (2014) Fertility of Women in the United States: June 2012. Current 
Population Reports, U.S. Census Bureau, Washington, DC, p20-575. 
 56 
 
 
Mosher, W. D., & Jones, J. (2010). Use of contraception in the United States: 1982–2008. 
Vital and Health Statistics. 23 (29), 1-44. 
 
National Cancer Institute. (2012). HPV and cancer. Retrieved from: http://www.cancer.gov/ 
cancertopics/causes-prevention/risk/infectious-agents/hpv-fact-sheet 
 
National Cancer Institute (2005). Theory at a Glance: A Guide for Health Promotion Practice 
(second edition). 
 
National Institutes of Health. (1996). Cervical Cancer. NIH Consensus Statement, 14(1), 1-38. 
 
National Women’s Law Center. (2009). Still Nowhere to Turn: Insurance companies treat 
women like a pre-existing condition.  
 
Nelson, D. E., Bland, S., Powell-Griner, E., et al. (2002). State trends in health risk factors and 
receipt of clinical preventive services among US young adults during the 1990s. Journal 
of the American Medical Association, 287(20), 2659-2667. 
 
Ochsendorf, F. R. (2008). Sexually transmitted infections: Impact on male fertility. First 
International Journal of Andrology. 40, 72-75. 
 
Office of the Assistant Secretary for Planning and Evaluation [ASPE]. (2015). Health Insurance 
Coverage and the Affordable Care Act. Retrieved from: http://aspe.hhs.gov/pdf-
document/health-insurance-coverage-and-affordable-care-act 
 
Office of the Assistant Secretary for Planning and Evaluation [ASPE]. (2015). 2015 Poverty 
Guidelines. U.S. Department of Health & Human Services. Retrieved from: 
https://aspe.hhs.gov/2015-poverty-guidelines#guidelines 
 
Organisation for Economic Co-operation and Development [OECD]. (2014). OECD health 
statistics 2014: How does the United States compare? Retrieved from: 
http://www.oecd.org/unitedstates/Briefing-Note-UNITED-STATES-2014.pdf 
 
Paolacci, G., Chandler, J., & Ipeirotis, P. I. (2010). Running experiments on Amazon mechanical 
turk. Judgment and Decision Making, 5, 411–419. 
 
Patchias, E. M., & Waxman, J. (2007). Women and health coverage: The affordability gap. Issue 
Brief (Commonwealth Fund), 25, 1–12. 
 
 57 
 
Peipert, J. F., Madden, T., Allsworth, J. E., Secura, G. M. (2012). Preventing unintended 
pregnancies by providing no-cost contraception. Obstetrics & Gynecology, 120(6), 1291-
1297. 
 
Population Division, U.S. Census Bureau. (2015). Annual Estimates of the Resident Population: 
April 1, 2010 to July 1, 2015. Retrieved from: 
http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=PEP_2
015_PEPANNRES&src=pt 
 
Population Division, U.S. Census Bureau. (2015). Annual estimates of the residential population 
by sex, race, and Hispanic origin for the United States, states, and counties: April 1, 2010 
to July 1, 2014. Retrieved from: 
http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk 
 
Pourat, N., Tao, G., & Walsh, C. (2008). Association of insurance coverage with chlamydia 
screening. The American Journal of Managed Care, 14(4), 197-204. 
 
Rasinsky, K. A. (1989). The effect of question wording on public support for government 
spending. Public Opinion Quarterly, 53, 388–394. 
 
Ratanasiripong, N. T. (2012). A review of human papillomavirus (HPV) infection and HPV 
vaccine-related attitudes and sexual behaviors among college-aged women in the United 
States. Journal of American College health, 60(6), 461-470. 
 
Ricketts, S., Klingler, G., & Schwalberg, R. (2014). Game Change in Colorado: Widespread Use  
 Of Long‐Acting Reversible Contraceptives and Rapid Decline in Births among Young, 
Low‐Income Women. Perspectives on Sexual and Reproductive Health, 46(3), 125-132. 
 
Rodriguez, M. A., Ward, L. M., Perez-Stable, E. J. (2005). Breast and cervical cancer 
screening: Impact of health insurance status, ethnicity, and nativity of Latinas. Annual 
Family Medicine, 3, 235-41. 
  
 Rose SB, Cooper AJ, Baker NK, Lawton B. Attitudes toward long-acting reversible 
contraception among young women seeking abortion. J Womens Health (Larchmt) 
2011;20:1729–35. 
 
Rosenstock, I. M. (1960). What research in motivation suggests for public health. American 
Journal of Public Health, 50, 295–301.  
 
Rosenstock, I. M. (1966). Why people use health services. Milbank Memorial Fund 
Quarterly, 44, 94–124.  
 
 58 
 
Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education 
Monographs, 2, 328–335. 
 
Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., Vichnin, M. D. (2011). 
Predictors of HPV vaccine uptake among women aged 19-26: Importance of a 
physician’s recommendation. Vaccine. 29, 890-895. 
 
Ross, J., Irani, L., Silberman, M., Zaldivar, A., & Tomlinson, B.(2010).Who are the crowdworkers? 
Shifting demographics in Mechanical Turk. In E. Mynatt, K. Edwards, & T. Rodden (Eds.), 
CHI EA ’10: Proceedings of the 28th of the international conference extended abstracts on 
human factors in computing systems (pp.2863–2872). New York, NY: ACM. 
 
Sabik, L. M., Bradley, C. J. (2016). The impact of near-universal insurance coverage on breast 
and cervical cancer screening: Evidence from Massachusetts. Health Economics, 25, 391-
407. 
 
Sayil, M., A. Güre, and Z. Uçanok. 2007. First time mothers’ anxiety and depressive symptoms 
across the transition to motherhood: Associations with maternal and environmental 
characteristics. Women Health 44:61–77. 
 
Sensoy, N., Dogan, N., Sen, K., Aslan. H., Baser, A. T. (2015). Unwanted pregnancy and 
traditional self-induced abortion methods known among women aged 15-49.  
 
Shapiro, D. N., Chandler, J., & Mueller, P. A. (2013). Using Mechanical Turk to study clinical 
populations. Clinical Psychological Science, 1 (2), 213-220. 
 
Simons, D. J., Chabris, C. F. (2012). Common (mis)beliefs about memory: A replication and 
comparison of telephone and Mechanical Turk Survey Methods. PLos ONE, 7(12), 
e51876. doi:10.1371/journal.pone.0051876. 
 
Smith, R. A., Cokkinides, V., Eyre, H. J., (2005). American Cancer Society guidelines for the 
early detection of cancer. CA Cancer J Clin, 55(1), 31-44.  
 
Smith, J. C., Medalia, C., US Census Bureau. (2015). Health insurance coverage in the United 
States: 2014. U.S. Government Printing Office, Washington, DC, P60-253. 
 
Sokkary, N., Mansouri, R., Yoost, J., Focseneanu, Dumont, T., Nathwani, M., Allen, L., 
Hertweck, S. P., Dietrich, J. E. (2013). A multicenter survey of contraceptive knowledge 
among adolescents in North America. Journal of Pediatric and Adolescent Gynecology, 
26(5), 274-276.  
 
 59 
 
Sommers, B. D., Long, S. K., Baicker, K. (2014). Changes in mortality after Massachusetts 
health care reform: A quasi-experimental study. Annals of Internal Medicine. 160(9), 
585-593.  
 
Sobel, L., Salganicoff, A., Kurani, N., Wiens, J., Hawks, K., Shields, L. (2015). Coverage of 
contraceptive services: A review of health insurance plans in five states. The Henry J. 
Kaiser Family Foundation. 
 
Sonfield, A., Kost, K., Benson Gold, R., & Finer, L. (2011). The public costs of births resulting 
from unintended pregnancies: National and state-level estimates. Perspectives on Sexual 
and Reproductive Health, 43(2), 93–102. 
 
Sonier, J., Boudreaux, M., & Blewett, L. (2013). Medicaid 'welcome-mat' effect of Affordable 
Care Act implementation could be substantial. Health Affairs (Project Hope),32(7), 
1319-25. 
 
Stephens, S., Cohen, S., Philip, S., & Bernstein, K. (2014). Insurance among patients seeking 
care at a municipal sexually transmitted disease clinic: Implications for health care 
reform in the United States. Sexually Transmitted Diseases, 41(4), 227-32. 
 
Stranges, E., Wier, L., & Elixhauser, A. (2012). Complicating conditions of vaginal deliveries 
and cesarean sections, 2009. HCUP Statistical Brief #131. Rockville, MD: Agency for 
Healthcare Research and Quality. 
 
Teal, S. B., Romer, S. E. (2013). Awareness of long-acting reversible contraception among teens 
and young adults. Journal of Adolescent Health, 52(4 Suppl), S35-S39. 
 
The Alan Guttmacher Institute (AGI). (2000). Fulfilling the promise: Public policy and the 
U.S. family planning clinics. New York: AGI.  
 
The Alan Guttmacher Institute (AGI). (2012). Contraceptive use in the United States. 
Retrieved from: http://www.guttmacher.org/pubs/fb_contr_use.html. 
 
Thornburn, S., Bogart, L. M. (2005). African American women and family planning services: 
Perceptions of discrimination. Women’s Health, 42, 23 – 29. 
 
Trussel, J. (2011). Contraceptive failure in the United States. Contraception. 83(5), 397-404. 
 
Tversky, A., Kahneman, D. (1981). The framing of decisions and the psychology of choice. 
Science, 211, 453-458. 
 
 60 
 
Zimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., Vichnin, M. D. (2010). Reasons 
for non-vaccination against HPV and future vaccination intentions among 19-26 year 
old women. BMC Women’s Health. 10-27. 
 
University of Twente. (2016). Health belief model. Retrieved from: 
https://www.utwente.nl/cw/theorieenoverzicht/Theory%20Clusters/Health%20Communi
cation/Health_Belief_Model/ 
 
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012 Incidence and 
Mortality Web-based Report. Atlanta (GA): Department of Health and Human Services, 
Centers for Disease Control and Prevention, and National Cancer Institute; 2015. 
US Census Bureau. (2015) Statistical Abstract of the United States. Retrieved from: 
http://www.census.gov/compendia/statab/2012/tables/12s0080.pdf 
 
Van Der Wees, P. J., Zaslavsky, A. M., & Ayanian, J. Z. (2013). Improvements in health status 
after Massachusetts health care reform. The Milbank Quarterly, 91(4), 663-689. 
 
Ward, B. W., Clarke, T. C., Freeman, G., Schiller, J. S. (2015). Early release of selected 
estimates based on data from 2014 National Health Survey. National Center for Health 
Statistics.  Available from: http://www.cdc.gov/nchs/nhis.htm 
 
World Health Organization. (2011). Knowledge for health project. Family planning: A global 
handbook for providers.  Baltimore, MD.  
 
Yacobi, E. Tennant, C., Ferrante, J., Pal, N., Roetzheim, R. (1999). University students’ 
knowledge and awareness of HPV. Preventive Medicine, 28(6), 535-541. 
 
 
 61 
 
APPENDIX A: 
 
RESEARCH SUBJECT INFORMATION AND CONSENT FORM 
TITLE: Knowledge and Use of Health Services 
 
VCU IRB NO.: HM20005824 
 
PURPOSE OF THE STUDY  
The purpose of this research study is to examine the relationships between individual knowledge 
of the PPACA, the use of preventive reproductive health services, and possession of insurance 
coverage. 
 
DESCRIPTION OF THE STUDY AND YOUR INVOLVEMENT 
If you decide to participate in this research study, you will be asked to consent to participate by 
selecting “I choose to participate in this study,” after you have had all your questions answered 
and understand what the study will involve. 
 
After consenting to participate in the study, you will be directed to a brief demographic survey. 
The study requires the possession of certain demographic characteristics in order to participate. If 
you do not qualify for the study, then you will be redirected out of the survey and will not 
receive compensation. If you do meet the demographic qualifications, then you will be taken to 
the next section of the study.  
 
Your participation will last approximately 25 minutes. Topics covered will include: demographic 
characteristics, insurance knowledge and use, sexual health behaviors, items pertaining to your 
reproductive medical history, and health service use during the previous year. All of your 
responses will remain confidential, so the answers that you provide will not be released to 
anyone. 
 
RISKS AND DISCOMFORTS 
Sometimes discussing personal health issues and behaviors cause people to become embarrassed 
or upset. You may stop participating in the research at any time.  If you become upset, you may 
contact the research team using the information at the end of this form. 
 
BENEFITS TO YOU AND OTHERS 
The information we learn from people in this study may help us better understand how people 
understand and utilize health services in the United States. 
 
COSTS 
There are no costs for participating in this study other than the time you will spend completing 
the survey. 
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COMPENSATION 
You will be compensated $0.45 for your participation in this research study. In order to receive 
compensation, you must correctly answer 2 out of 3 quality assurance questions that are 
randomly placed throughout the questionnaire. 
 
CONFIDENTIALITY 
Data are being collected only for research purposes. MTurk automatically collects participants’ 
IP addresses; however, we will not retain your IP address in our saved records or link your 
survey responses to your IP addresses in any saved databases, publications, presentations, or any 
other format. 
 
Information from the study and your consent to participate may be looked at or copied for 
research or legal purposes by Virginia Commonwealth University. What we find from this study 
may be presented at conferences or published in scholarly papers. Your answers will remain 
confidential, as we will discard your IP addresses before data is stored and we are not collecting 
your name or other identifiable information. 
 
COMPUTER USE 
If possible, please take this survey on your personal computer. 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
You do not have to participate in this study. If you choose to participate, you may stop at any 
time without any penalty. You may also choose not to answer particular questions that are asked 
in the study.  
 
QUESTIONS 
In the future, you may have questions about your participation in this study. If you have any 
questions, complaints, or concerns about the research, contact: 
 
            Dr. Eric Benotsch 
            808 W. Franklin St., #208 
            Richmond, VA 23284 
            E-mail:  ebenotsch@vcu.edu 
            Phone:  804-828-0133 
If you have any questions about your rights as a participant in this study, you may contact: 
 Office for Research 
 Virginia Commonwealth University 
 800 East Leigh Street, Suite 113 
 P.O. Box 980568 
 Richmond, VA  23298 
 Telephone:  804-827-2157 
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You may also contact this number for general questions, concerns or complaints about the 
research.  Please call this number if you cannot reach the research team or wish to talk to 
someone else.  Additional information about participation in research studies can be found at 
http://www.research.vcu.edu/irb/volunteers.htm. 
 
CONSENT 
I have been given the chance to read this consent form. I understand the information about this 
study. Questions that I wanted to ask about the study have been answered. I am stating that I am 
willing to participate in this study. I also verify that I am 18 years of age or older and live in the 
United States. 
 I choose to participate in this study. 
 I choose to not participate in this study. 
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APPENDIX B: 
STUDY QUESTIONNAIRE 
 
Instructions: Please answer the following questions to the best of your ability: 
 
1. Age: ___  
 
2. Gender:  
 Male 
 Female 
 Transgender Male 
 Transgender Female 
 Gender Non-Conforming 
 Other ____________ 
 
3. Which race/ ethnicity best describes you:   
 Caucasian 
 African American 
 Hispanic/ Latino 
 Asian 
 American Indian or Alaskan Native 
 Native Hawaiian or Other Pacific Islander 
 Other________________ 
 
4. Sexual Orientation:  
 Heterosexual/ Straight 
 Homosexual/ Gay 
 Bisexual 
 Other _______________ 
 
5 Relationship Status: 
 Not currently dating or in a relationship   
 In a newer relationship with 1 person (less than 12 months)  
 In a long-term relationship with 1 person (12 months or longer)  
 Married   
 Dating/ in a relationship with more than 1 person 
 
6. Highest level of education completed: 
 Middle school 
 High school 
 GED 
 Vocational school 
 Associates Degree 
 Bachelor Degree 
 Graduate Degree (Masters, Doctorate, etc.) 
 
7. Political Affiliation:  
 Democrat 
 Republican 
 Independent 
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 Libertarian 
 Green 
 Other ____________ 
 None 
 
8. How many people live in your household? ______ 
 
9. How many of the people living in your household are dependent children 
 
10. Please report the amount that best describes your household yearly income BEFORE taxes (Note: this 
amount should include all income, including veterans’ payments, child support, alimony, and assistance 
from outside of the household; however, it should exclude food stamps and housing subsidies): 
___________  
 
11. What state do you currently live in (Please provide the abbreviation – e.g., “CA” for California): _____  
 
12. Of the following, please choose the option that best describes your highest level of employment (e.g., if 
you have both a part-time and a full-time job, choose "full time"):   
 Not employed 
 Student 
 Employed part-time 
 Employed full-time 
 Retired 
 
13. What is your primary news source?  
 New York Times  Huffington Post  USA Today  Local Newspaper 
 CNN  Washington Post  LA Times  Local TV News 
 MSNBC  ABC News  Yahoo! News  National TV News 
 Fox News  BBC News  NPR  PBS 
 
14. Out of the past year, which option best describes the amount of time that you had health insurance 
coverage?  
 I was not insured at all in the past year 
 I was insured for 1-6 months out of the last year   
 I was insured for 7-11 months out of the last year 
 I was insured for all 12 months of the last year 
 
15. What type(s) of health insurance plan(s) have you had in the past year?   
 Private Insurance       
o A plan through an employer       
o Federal Government Insurance (for federal employees)   
o A plan through the government exchange/ Marketplace   
o Coverage through a parent’s plan     
o A university plan       
o I’m not sure        
o I did not have any insurance coverage during the last year   
 Public Insurance       
o Military Insurance (i.e., Tricare)      
o Medicaid/ State program insurance     
o Medicare        
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o Veteran Benefits       
o I’m not sure        
o I did not have any insurance coverage during the last year  
 I did not have any insurance coverage during the last year  
 
16. Have you had insurance coverage from 2 or more policies at the same time in the past year?  
 Yes  No  I don’t know 
 
17. Are you the policy holder or a dependent?    
 I’m the policy holder (the insurance is in my name) 
 I am a dependent, and the policy is through my spouse 
 I am a dependent, and the policy is through my parent(s) 
 I am a dependent, and the policy is through a different legal guardian 
 
18. Did you have insurance before the health insurance marketplace opened under the Affordable Care Act in 
October 1, 2013?   
Yes  No  I don’t know 
 
19. In the last year, did you receive a subsidy from the government to help pay for your health insurance plan? 
Yes  No  I don’t know   
 
20. A grandfathered health insurance plan is a group health plan that was created—or an individual health 
insurance policy that was purchased—on or before March 23, 2010. Do you have a “Grandfathered” 
insurance plan?  
Yes  No  I don’t know   
 
21. Have you had difficulty affording the monthly premiums required to pay for your insurance coverage in 
the past year?    
Yes  No 
 
22. Approximately how many times have you visited a doctor’s office in the past year?  
0 times  1 time  2-5 times  6-9 times  10+ times  
 
23. Approximately how many times have you visited a free clinic in the past year?  
0 times  1 time  2-5 times  6-9 times  10+ times  
 
24. Approximately how many times have you visited an emergency room in the past year?  
0 times  1 time  2-5 times  6-9 times  10+ times  
 
25. Do you have a chronic health condition?    
Yes  No 
 
26. Do you have a reproductive health issue?  
Yes  No 
 
 
Instructions: Please indicate whether you have received the following services in the past year: 
27. Vaginal pelvic exam     
Yes  No 
 
28. Breast Exam      
Yes  No 
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29. Well woman’s visit     
Yes  No 
 
 Physical       
Yes  No 
 
30. HPV vaccination     
Yes  No 
 
31. Gonorrhea/Chlamydia testing   
Yes  No 
 
32. HIV testing     
Yes  No  
 
33. Syphilis testing     
Yes  No 
 
34. Genital Herpes testing    
Yes  No 
 
35. Birth control counseling (someone discussing birth control options with you and how they work)   
Yes  No   
 
36. Birth control visit to receive a prescription (for pills, patches, or Nuvaring)   
Yes  No   
 
37. Birth control procedure [Depo injection (“the shot”), the arm implant, IUD (intrauterine device) insertion, 
male or female sterilization]  
Yes  No   
 
38. Reproductive/ sexual health education through a doctor  
Yes  No   
 
39. Prenatal care     
Yes  No 
 
40. Abortion       
Yes  No 
 
41. Care for miscarriage management    
Yes  No 
 
42. Flu Shot      
Yes  No 
 
43. When was the last time that you received a pap smear? Even if you are unsure of the exact date, please 
provide your best estimate. _________  
 
44. Have any of your female family members (i.e., sister, mother, aunt, grandmother) been diagnosed with a 
form of reproductive cancer (e.g., ovarian, cervical, breast, etc.)?  
Yes  No 
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Instructions: Please indicate whether you have used the following birth control methods in the past year: 
45. None       
Yes  No 
 
46. Abstinence      
Yes  No 
 
47. Male condoms      
Yes  No   
 
48. Female condoms     
Yes  No   
 
49. Fertility Awareness-Based Methods (i.e. The Temperature Method, The Cervical Mucus Method, The 
Calendar Method, etc.)     
Yes  No  
 
50. Breast Feeding      
Yes  No   
 
51. Rhythm       
Yes  No   
 
52. Withdrawal      
Yes  No   
53. Diaphragm      
Yes  No  
  
54. Cervical cap     
Yes  No 
   
55. Sponge       
Yes  No   
 
56. Spermicide      
Yes  No   
 
57. Birth control pills     
Yes  No   
   
58. The morning after pill/ Plan-B  
Yes  No   
 
59. Patch       
Yes  No   
 
60. Vaginal ring      
Yes  No   
 
61. Depo Provera Injection     
Yes  No   
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62. Arm implant (Implanon, Nexplanon)    
Yes  No  
 
63. IUD (Skyla, Mirena, Liletta, Paragard)   
Yes  No   
64. Sterilization (e.g., Tubal Ligation, Hysterectomy, Essure)   
Yes  No  
 
65. Sterilization of a male partner (Vasectomy) 
Yes  No  
 
Please answer each of the following questions by circling the number that best describes your opinion. Some 
of the questions may appear to be similar, but they do address somewhat different issues. Please read each 
question carefully.  
 
For me to use a method of birth control would be:  
66. Extremely Bad : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Good 
 
67. Extremely Unreliable : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Reliable 
 
68. Extremely Worthless : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Valuable 
 
69. Extremely Unnecessary  : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Necessary 
 
70. Extremely Embarrassing : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Comforting 
 
71. Most people who are important to me approve of me using birth control 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
72. My partner/ significant other approves of me using birth control 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
73. Most people who are like me use birth control 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
74. It is expected of me to use birth control 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
75. Using birth control is up to me 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
76. I am confident I can find a place to receive birth control prescriptions or devices. 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
77. I intend to obtain birth control in the future 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
78. I will make an effort to obtain birth control in the future 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
79. If birth control was free from your health provider, how likely is it that you would use it? 
Very Unlikely      Not Likely       Likely    Very Likely      
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80. I am not at risk for becoming pregnant  
True  False 
 
81. Are you currently using a clinical method of birth control (i.e., pill, patch, ring, injectable/ shot, arm 
implant, IUD)?       
Yes  No 
 
82. If yes  What form of clinical birth control are you using (please be as specific as possible)? ______  
 How long have you been using this method of birth control? Even if you are unsure, please 
provide your best estimate. _______  
 
If no  Please indicate the level to which each of these factors influences your decision NOT to use birth 
control (excluding condoms):  
83. I do not feel that I am at risk for becoming pregnant 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
84. My doctor told me that I cannot become pregnant 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
85. The cost of birth control 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
86. I am fearful of medical environments/ doctor’s offices 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
87. A lack of transportation 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
88. A long distance or lack of transportation/ Having to go to the pharmacy to receive it 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
89. It is okay if I become pregnant/ I am not worried about becoming pregnant 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
90. I am trying to become pregnant 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
91. I am worried about side effects of birth control  
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
92. I do not know enough about how to get birth control  
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
93. I do not know enough about the different types of birth control/ I do not know which birth control to 
choose [11] 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
94. I have had bad experiences with birth control in the past  
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
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95. I do not trust birth control to prevent pregnancy 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
96. I have become pregnant while on birth control 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
97. I rely on condoms 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
98. Birth control violates my personal/ religious beliefs 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
99. OTHER __________ 
 
100. Have you ever used the morning after pill/ Plan-B?  
Yes   No 
 
101. Do you rely on the morning after pill/ Plan-B as your primary method of birth control?  
Yes   No   
 
102. Do you rely on the morning after pill/ Plan-B as a strong back-up plan if birth control fails? 
Yes  No   
 
103. Have you had trouble affording copays, deductibles, or other medical bills when utilizing of any of the 
services detailed in the previous questions (e.g., STI screenings, cancer screenings, birth control services) 
as required by your insurance within the past year?   
Yes  No  I did not have health insurance this past year 
 
 
Please answer each of the following questions by circling the number that best describes your opinion. Some 
of the questions may appear to be similar, but they do address somewhat different issues. Please read each 
question carefully.  
 
For me to receive preventive cancer screenings: 
104. Extremely Bad : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Good 
 
105. Extremely Unreliable : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Reliable 
 
106. Extremely Worthless : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Valuable 
 
107. Extremely Unnecessary  : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Necessary 
 
108. Extremely Embarrassing : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Comforting 
 
109. Most people who are important to me approve of me receiving preventive cancer screenings  
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
110. My partner/ significant other approves of me receiving preventive cancer screenings  
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
111. Most people who are like me receive preventive cancer screenings 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
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112. It is expected of me to receive preventive cancer screenings 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
113. Receiving preventive cancer screenings is up to me 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
114. I am confident I can find a place to receive preventative cancer screenings. 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
115. I intend to obtain preventive cancer screenings in the future 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
116. I will make an effort to obtain preventive cancer screenings in the future 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
Instructions: Please answer the following questions to the best of your ability: 
117. Did you experience an intended pregnancy in the last year?    
Yes  No 
 
118. Did you experience an unintended pregnancy in the last year?    
Yes  No 
 
119.  Were you trying to become pregnant in the last year?     
Yes  No 
 
120. Were you unconcerned with whether or not you became pregnant in the last year (i.e. not actively trying 
to become pregnant, but also not actively trying to prevent pregnancy)?   
Yes  No 
 
121. All my friends say I would make a great Poodle  
True  False 
 
122. How many times in the past year have you received STI testing?    
0 times  1 time  2-5 times        6-9 times              10+ times  
 
123. Please indicate any of the following STIs that you have been diagnosed with in the past year:   
 Gonorrhea 
 Chlamydia   
 HIV  
 Syphilis  
 Genital Herpes 
 Genital Warts 
 Trichomoniasis (Trich) 
 
124. Please indicate any of the following STIs that you have been diagnosed with in your lifetime:  
 Gonorrhea 
 Chlamydia   
 HIV  
 Syphilis  
 Genital Herpes 
 Genital Warts 
 Trichomoniasis (Trich) 
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Please answer each of the following questions by circling the number that best describes your opinion. Some 
of the questions may appear to be similar, but they do address somewhat different issues. Please read each 
question carefully.   
 
For me to receive testing for STIs (sexually transmitted infections): 
125. Extremely Bad : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Good 
 
126. Extremely Unreliable : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Reliable 
 
127. Extremely Worthless : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Valuable 
 
128. Extremely Unnecessary : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Necessary 
 
129. Extremely Embarrassing : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Comforting 
 
130. Most people who are important to me approve of me receiving testing for STIs 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
131. My partner/ significant other approves of me receiving testing for STIs 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
132. Most people who are like me receive testing for STIs 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
133. It is expected of me to receive testing for STIs 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
134. Receiving testing for STIs is up to me 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
135. I am confident I can find a place to receive STI testing. 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
136. I intend to obtain testing for STIs in the future 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
137. I will make an effort to obtain testing for STIs in the future 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
138. Has a doctor ever suggested that you receive STI testing?  
  Yes   No 
 
139. If STI testing was free from your health provider, how likely is it that you would be tested?  
Very Unlikely      Not Likely  Likely  Very Likely 
 
140. I am not at risk for contracting a sexually transmitted infection (STI)   
True   False 
 
141. If yes  On what date did you receive your last STI screening? Even if you are unsure, please enter a 
numerical date. _____   
 
If no  Please indicate the level to which each of these factors influences your decision NOT to be tested 
for STIs (HIV, Syphilis, Gonorrhea, Chlamydia, Herpes, etc.):  
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142. The cost of the tests 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
143. I have a fear of needles 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences  
 
144. I have a shy bladder (inability to urinate in public spaces) 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
145. I am fearful of medical environments/ doctor’s offices 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
146. A lack of transportation  
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
147. I am not worried about contracting STIs 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
148. I am not sexually active 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
149. I do not know enough about the process 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
150. I am fearful of the results of the tests 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
151. I fear that I will test positive for an STI 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
152. I have been with the same partner for a long time 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
153. I always use condoms as protection for ALL sexual acts 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
154. STI testing violates my personal/ religious beliefs 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
155. OTHER __________ 
 
Access to Care 
156. If you were feeling ill or experiencing pain, how many days would it take you to go to the doctor? 
_______ 
 
157. How hard do you think it would be to find a provider or clinic where you don’t have to wait long to get an 
appointment?  
Not hard at all   Somewhat Hard  Very Hard 
 
Please indicate how much you agree or disagree with the following statements: 
158. I am confident I can find a place to receive prenatal care.  
Strongly Disagree  Slightly Disagree  No Opinion Slightly Agree  Strongly Agree 
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159. I am confident I can find a place to receive abortion care.  
Strongly Disagree  Slightly Disagree  No Opinion Slightly Agree  Strongly Agree 
 
Condom use/ Protection 
160. I ALWAYS use a condom with vaginal and/or anal sex   
Yes  No 
 
161. I ALWAYS use protection for oral sex (condom/ dental dam)  
Yes  No 
 
162. Condoms are the only method of birth control that I use   
Yes  No 
 
163. I use condoms in addition to another birth control method(s)   
Yes  No 
 
Please answer each of the following questions by circling the number that best describes your opinion. Some 
of the questions may appear to be similar, but they do address somewhat different issues. Please read each 
question carefully.   
 
For me to receive the vaccine for HPV (Human Papillomavirus):  
164. Extremely Bad : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Good 
 
165. Extremely Unreliable : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Reliable 
 
166. Extremely Worthless : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Valuable 
 
167. Extremely Unnecessary : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Necessary 
 
168. Extremely Embarrassing : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Extremely Comforting 
 
169. Most people who are important to me approve of me receiving the HPV vaccine 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
170. My partner/ significant other approves of me receiving the HPV vaccine 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
171. Most people who are like me get the HPV vaccine 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
172. It is expected of me to receive the HPV vaccine 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
173. Receiving the HPV vaccine is up to me 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
174. I am confident I can find a place to receive the Gardasil vaccine. 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
175. I intend to obtain the HPV vaccine in the future 
Strongly Disagree : __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
 
176. I will make an effort to obtain the HPV vaccine in the future 
Strongly Disagree: __1__: __2__ : __3__: __4__: __5__: __6__: __7__: Strongly Agree 
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177. Has a doctor ever suggested that you receive the HPV vaccine?  
 Yes  No 
 
178. If the HPV vaccine was free from your health provider, how likely is it that you would receive the vaccine 
within 6 months?        
Very Unlikely       Not Likely           Likely    Very Likely          N/A I have received it 
 
179. Have you received at least one dose of the HPV vaccine?   
Yes  No 
 
180. If yes  How many doses have you received? Please enter a number. ______  
 If < 3  When was your last dose? Even if you are unsure, please enter a numerical date that is 
your best guess. _____      
 
If no  Please indicate the level to which each of these factors influences your decision to NOT receive 
the HPV vaccine:        
181. The cost of the vaccine 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
182. I am concerned about the side effects of the vaccine 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
183. I have a fear of needles  
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
  
184. I am fearful of medical environments/ doctor’s offices 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
185. A lack of transportation 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
186. I do not know enough about it 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
187. I do not believe that the vaccine works 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
188. I do not believe that the vaccine is safe 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
189. The vaccine is too new  
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
190. I am not sexually active  
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
191. I am not worried about contracting HPV 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
 
192. HPV vaccines violate my personal/ religious beliefs 
Does not influence          Slightly Influences Moderately Influences  Majorly Influences 
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193. OTHER __________ 
 
Please respond to the following items to the best of your ability. If you don’t know, please do not guess; 
instead, please select “Don’t Know”.   
194. Genital Herpes is caused by the same virus as HIV.        
 True  False  Don’t Know 
 
195. There is a cure for Gonorrhea.          
 True  False  Don’t Know 
 
196. It is easier to get HIV if a person has another Sexually Transmitted Infection     
 True  False  Don’t Know 
 
197. Soon after infection with HIV, a person develops open sores on his or her genitals (penis or vagina).   
True  False  Don’t Know 
 
198. There is a cure for Chlamydia.          
 True  False  Don’t Know 
 
199. A man must have vaginal sex to get Genital Warts.        
 True  False  Don’t Know 
 
200. Sexually Transmitted Infections can lead to health problems that are usually more serious for men than 
women.  
True  False  Don’t Know 
 
201. A person who has Genital Herpes must have open sores to give the infection to his or her sexual partner. 
 True  False  Don’t Know 
 
202. If a person had Gonorrhea in the past, he or she is immune (protected) from getting it again.   
 True  False  Don’t Know 
 
203. A person can tell by the way their body feels if they have a Sexually Transmitted Infection (STI). 
True  False  Don’t Know 
 
 
Please respond to the following items to the best of your ability. If you don’t know, please do not guess; 
instead, please select “Don’t Know.”   
204. When putting on a condom, it is important to leave a space at the tip.  
True  False  Don’t Know 
 
205. When using a condom, it is important for the man to pull out right after ejaculation.  
True  False  Don’t Know 
 
206. Birth control pills are effective even if a woman misses taking them for two or three days in a row.  
True  False  Don’t Know 
 
207. Women should “take a break” from the pill every couple of years.  
True  False  Don’t Know 
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208. Birth control pills reduce the chances that women will get certain types of cancer.  
True  False  Don’t Know 
 
209. After a woman stops taking birth control pills, she is unable to get pregnant for at least two months.  
True  False  Don’t Know 
 
210. Women using the vaginal ring, NuvaRing, must have it inserted by a doctor or health care provider every 
month.     
True  False  Don’t Know 
 
211. Women using the birth control shot, Depo-Provera, must get an injection every three months.  
True  False  Don’t Know 
 
212. Even if a woman is late getting her birth control shot, she is still protected from pregnancy for at least 
three more months.  
True  False  Don’t Know 
 
213. A woman can use an IUD even if she has never had a child.  
True  False  Don’t Know 
 
214. Women who use IUDs cannot use tampons.  
True  False  Don’t Know 
 
215. To obtain an IUD, a woman must undergo a surgical operation.  
True  False  Don’t Know 
 
216. An IUD can be felt in the vaginal canal by a woman’s partner during sex.  
True  False  Don’t Know 
 
217. Long-acting methods like the implant or IUD cannot be removed early, even if a woman changes her 
mind about wanting to get pregnant.  
True  False  Don’t Know 
 
218. I have been to every country in the world.    
True  False  Don’t Know 
 
219. Have you heard of the Affordable Care Act?   
Yes   No 
 
220. Have you heard of Obamacare?   
Yes  No 
 
221. In general do you favor, oppose, or neither favor nor oppose the law changing the health care system  
  (the Affordable Care Act) that the U.S. Congress passed in March 2010?   
 Favor strongly 
 Favor somewhat 
 Neither favor nor oppose 
 Oppose somewhat 
 Oppose strongly 
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Instructions: Please indicate whether you believe the following statements about the Affordable Care 
Act to be True or False. The Affordable Care Act:   
222. Allows young adults to get health insurance by being included in their parents’ health insurance policies 
until they turn 26.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
223. Requires insurance companies to charge an additional fee of $1,000 a year to anyone who buys insurance 
from them and smokes cigarettes.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
224. Requires that anyone applying for a job must tell the employer if he or she has ever had any serious 
diseases.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
225. Requires companies to sell health insurance to U.S. citizens and legal immigrants who don’t have health 
insurance and have a serious medical problem.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
226. Insurance companies are able to deny coverage to individuals with pre-existing mental health disorders 
and substance use disorders.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
227. Insurance companies are able to deny coverage to individuals with pre-existing conditions.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
228. Prevents a health insurance company from limiting the amount of money that it will pay for a person’s 
health care costs during his or her life.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
229. Every state must expand Medicaid coverage to include those with incomes up to 138% of the federal 
poverty level, childless adults, and those without disabilities.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
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230. Requires some doctors to treat illegal immigrants free of charge if they cannot afford to pay  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
231. If a woman becomes pregnant and then decides to purchase insurance, she is able to gain coverage.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
232. Non-grandfathered plans must cover select preventative care and wellness services without charging 
deductibles, copays, or coinsurance.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
233. Immunizations are considered preventative care.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
234. Non-grandfathered plans must include maternity and newborn care as an essential health benefit.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
235. Non-grandfathered plans are not required to provide breastfeeding support, counseling, and equipment to 
those who are pregnant or nursing.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
236. Non-grandfathered plans must include abortion as an essential health benefit.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
237. Non-grandfathered plans must cover all types of birth control methods without charging deductibles, 
copays, or coinsurance.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
238. Non-grandfathered plans must cover preventative laboratory services, such as cardiovascular disease and 
diabetes screenings  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
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239. Provide discounts on prescriptions to seniors with high drug costs.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
240. Medicaid is not required to provide preventative screenings at no cost to the patient.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
241. Medicaid is not required to cover birth control methods at no cost to the patient.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
242. Grandfathered plans are not required to follow the essential health benefit requirements.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
243. Grandfathered plans must cover all types of birth control methods without charging deductibles, copays, 
or coinsurance.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
244. Non-grandfathered plans include preventative screenings (e.g., breast cancer screening and prostate 
exams) as essential health benefits, making these services free for the individual.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
245. Require that if a U.S. citizen does NOT have health insurance, that person will have to pay a fine on his 
or her federal income taxes unless he or she is allowed not to have the insurance for a series of specific 
reasons, such as having a very low income.  
  True  False 
 How sure are you about this? 
  Not sue at all          slightly sure          moderately sure         very sure  extremely sure 
 
246. Create committees of people who will review the medical histories of some people and decide whether 
they can get medical care paid for by the federal government.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
247. Give money to pay for health insurance to people who are U.S. citizens and have very low incomes.  
  True  False 
 How sure are you about this? 
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  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
248. Require companies with less than 50 employees to provide health insurance to their employees or pay a 
fine to the federal government if they do not  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
249. Requires companies that sell health insurance to pay new fees to the federal government each year.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
250. Require companies that make drugs to pay new fees to the federal government each year.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
251. Require every American to show a government health care identification card in order to get medical 
care at a hospital  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
252. Make health insurance available so that any American can buy if he or she wants to.  
  True  False 
 How sure are you about this? 
  Not sure at all          slightly sure          moderately sure         very sure  extremely sure 
 
253. In the past 3 months, how many times have you had sex after having too much to drink? Even if you are 
not certain, please indicate the NUMBER that is your best estimate. _____________  
 
254. In the past 3 months, how many times have you had sex while you were under the influence of drugs 
(prescription or recreational)? Even if you are not certain, please indicate the NUMBER that is your 
best estimate. ______  
 
255. How many total MEN have you had sex with in the last 3 months?  Even if you are not certain, please 
indicate the NUMBER that is your best estimate.      ____________  
 
256. How many total MEN have you had sex with in your lifetime? Even if you are not certain, please 
indicate the NUMBER that is your best estimate. ____________ 
 
257. How many total WOMEN have you had sex with in the last 3 months? Even if you are not certain, 
please indicate the NUMBER that is your best estimate. _____________  
 
258. How many total WOMEN have you had sex with in your lifetime? Even if you are not certain, please 
indicate the NUMBER that is your best estimate.   ____________ 
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259. In the past 3 months, how many times did you have unprotected vaginal sex? Even if you are not 
certain, please indicate the NUMBER that is your best estimate. _____ times    
 
260. In the past 3 months, how many times did you have unprotected oral sex? Even if you are not certain, 
please indicate the NUMBER that is your best estimate. _____ times      
 
261. In the past 3 months, how many times did you have unprotected anal sex? Even if you are not certain, 
please indicate the NUMBER that is your best estimate. _____ times     
 
262. Did you use a condom during the last time you had vaginal or anal sex? 
  Yes   No 
263. What do you believe this study is about? ____________________________  
  
264. Please enter in a 6-digit code (that is NOT 123456) _______________   
 
 Please go back to the Amazon Mechanical Turk website and enter this same code into the HIT in 
order to receive compensation for your participation! 
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